Inhaler component

Abstract
The invention relates to an inhaler component for forming a vapor-air mixture and/or condensation aerosol by vaporizing a liquid material and optionally condensing the vapor formed, including: a heating element for vaporizing a portion of the liquid material; a wick for automatically supplying the liquid material to the heating element, wherein the wick comprises at least two end sections arranged apart from each other; a first capillary gap for automatically supplying the liquid material to the wick, wherein a first end section of the wick projects into the first capillary gap. In order that the heating element can be supplied more quickly and more reliably with the liquid material, a second capillary gap is provided, which receives therein the second end section of the wick.
Description
FIELD

The invention relates to an inhaler component for the formation of a vapor-air mixture or/and of a condensation aerosol by evaporating a liquid material and, if necessary, condensing the vapor formed, comprising: a heating element for the evaporation of a portion of the liquid material; a wick for the automatic supply of the heating element with the liquid material, the said wick having at least two end sections arranged at a distance from each other; a first capillary gap for the automatic supply of the wick with the liquid material, wherein a first end section of the wick extends into the first capillary gap.


BACKGROUND

Definition of terms: In the present patent application the term “inhaler” refers to medical as well as non-medical inhalers. The term refers furthermore to inhalers for the administration of drugs and materials which are not declared as drugs. The term refers, in addition, to smoking articles and cigarette substitutes, such as those in European patent class A24F47/00B, for example, as far as these are intended to supply the user with a vapor-air mixture or/and a condensation aerosol. The term “inhaler” also implies no restrictions on how the vapor-air mixture or/and condensation aerosol formed is supplied to the user or his body. The vapor-air mixture or/and condensation aerosol can be inhaled into the lungs or, in addition, only supplied to the oral cavity—without inhalation into the lungs.


“Capillary gap” means any gap which causes liquid transport solely on the basis of the capillary action of its confining walls. Wicks, wrapped wicks or channels filled with wick material are not capillary gaps.


WO 2010/045671 (Helmut Buchberger) describes an inhaler component for the intermittent, inhalation or pull-synchronous formation of a vapor-air mixture or/and condensation aerosol, consisting of (FIGS. 9 to 12 and FIGS. 17 to 18) a housing 3, a chamber 21 provided in the housing 3, an air intake opening 26 for the supply of air from the environment into the chamber 21 and an electric heating element for the evaporation of a portion of a liquid material 16, in which case the vapor formed mixes in the chamber 21 with the air supplied by the air intake opening 26 and the vapor-air mixture or/and condensation aerosol is or are formed. Furthermore, the inhaler component comprises a wick with a capillary structure, which wick forms with the heating element a laminar composite 22 and automatically resupplies the heating element with the liquid material 16 after evaporation. At least one heated section of the composite 22 is arranged without contact in the chamber 21 and the capillary structure of the wick lies exposed to a large extent in the said section at least on one side 24 of the laminar composite. One end of the laminar composite 22 projects into a capillary gap 41, which is coupled or is capable of being coupled by capillary to a liquid container 4 containing the liquid material 16. The capillary gap 41 draws the liquid material 16 from the liquid container 4 and conveys it to the wick.


After evaporation or inhalation the user of the inhaler component must observe a waiting period, during which the liquid material 16 can again completely infiltrate the wick. Evaporations before the expiration of the waiting period can lead to various disadvantageous consequences, for example a decrease in the given aerosol quantity or/and a local overheating of the wick, possibly associated with a decomposition of the liquid material and a degradation of the organoleptic characteristics of the vapor-air mixture or aerosol formed. In prototypes based on highly diluted ethanol or/and aqueous nicotine solutions, it was possible to obtain complete infiltration of the wick within 10 s. If the inhaler component is used as a cigarette replacement, then a waiting period of 10 s may be acceptable for many smokers; for some smokers, however, it may be too long. Furthermore, with the same prototypes it has been shown that even when the waiting period mentioned is adhered to, disturbances of the infiltration can occur. These disturbances rarely arise, but can lead to the same disadvantageous consequences as described above. The disturbances are characterized by an unsatisfactory wetting of the capillary structure of the wick by the liquid material and occur preferably locally, in regions of the wick which are peripheral in relation to the capillary gap.


SUMMARY

The object of the invention is to remedy the aforementioned disadvantages of the arrangement known from the state of the art. More particularly, it is the object of the invention to design an inhaler component of the type described in the preamble in such a way that the wick is infiltrated with the liquid material as rapidly as possible and no unpleasantly long waiting periods occur. Local disturbances of the infiltration are likewise to be avoided. All of this is to be achieved, if possible, without additional structural outlay. The production costs of the inhaler component should likewise not be increased.


This object is achieved by the characterizing features of claim 1. Accordingly, the inhaler component is provided with a second capillary gap, which holds the second end section of the wick. The wick is thus supplied with the liquid material from two sides. As a result, the waiting period for complete infiltration of the wick can be at least halved as compared with a conventional one-sided supply. If one considers that the infiltration of the wick with the liquid material takes place in a degressive-proportional manner, i.e. comparatively rapidly at the beginning and then more slowly, then it becomes clear that the waiting period for the complete infiltration of the wick by the arrangement according to the invention can be shortened by significantly more than 50%. Similarly advantageous effects result regarding the security of supply of the wick: the particularly endangered regions of the wick on the periphery in relation to the first capillary gap can now be reliably supplied with the liquid material over a short distance from the second capillary gap.


In a preferred embodiment of the invention it is provided that the first and second capillary gaps are connected to each other by a third capillary gap. The first and second capillary gaps thus communicate with each other via the third capillary gap. Thus any uneven supply of the first and second capillary gap with the liquid material can be equalized, and the security of supply to the wick further improved.


It is further provided according to the invention that one of the capillary gaps is coupled or capable of being coupled by capillary to a liquid container containing the liquid material. This capillary gap can for example be the first capillary gap. In this case the second capillary gap would be supplied with the liquid material exclusively via the third capillary gap. In addition, it could alternatively be provided that the third capillary gap is coupled or capable of being coupled by capillary to the liquid container. In this case the first and second capillary gaps would be supplied with the liquid material via the third capillary gap.


Conditions which are particularly simple structurally result if all the capillary gaps are situated in a common plane. A further structural simplification is obtained by all the capillary gaps being formed by a board, preferably a printed circuit board, and an upper section mounted on the board. In this case only two components are required to form all the capillary gaps.


In a first variant of embodiment the upper section has, according to the invention, a recess facing the board. The recess forms the capillary gaps in co-operation with the surface of the board, the depth of the recess setting the width of the capillary gaps. It is particularly advantageous for the recess to be bounded at least locally by one or more ventilation grooves. The ventilation grooves have the advantageous effect that the liquid material stored in the capillary gaps can be used more effectively as buffer volumes.


In a second alternative variant of embodiment the upper section is mounted on the end sections of the wick. The end sections of the wick act in this case as spacers which set the width of the capillary gaps. In this alternative variant of embodiment too, the upper section would be considered as being “mounted on the board”, even if the two components do not touch each other directly.


The board is preferably designed in the form of a printed circuit board and it serves as such for supplying electrical energy to the—in this case—electric heating element. In this case it is particularly advantageous for the printed circuit board to be designed in the form of a multiple-layer, so-called multilayer, printed circuit board. As a result, the conductive strips supplying the electric current can in this case be concentrated in layers which do not affect the capillary gaps. In addition, more complex arrangements of conductive strips can also be implemented by means of multilayer printed circuit boards, a circumstance which proves advantageous at the latest when a plurality of electric heating elements are provided, and the heating elements are to be actuated independently of one another. Finally, on account of the multiple-layer arrangement of their conductive strips, multilayer printed circuit boards allow comparatively high electric currents to be transmitted.


In a further arrangement of the invention it is provided that the first capillary gap is coupled or is capable of being coupled to a first liquid container containing the liquid material and the second capillary gap is coupled or is capable of being coupled to a second liquid container containing the liquid material. By providing two liquid containers essentially independent of each other the security of supply of the wick with the liquid material can once again be increased.


Expedient and advantageous embodiments of the invention are illustrated in the drawings and are explained in greater detail in the following description.





BRIEF DESCRIPTION OF THE DRAWINGS

In the drawings:



FIG. 1A shows a bottom view of an exemplary inhaler component according to the invention;



FIG. 1B shows a front view of an exemplary inhaler component according to the invention;



FIG. 1C shows a top view of an exemplary inhaler component according to the invention;



FIG. 2 is a longitudinal section through the inhaler component according to FIG. 1B at the level of the laminar composite;



FIG. 3 is a cutaway view of the inhaler component along the line A-A in FIG. 2;



FIG. 4 shows the detail from FIG. 3 in an enlarged view;



FIG. 5 is a cutaway view of the inhaler component along the line B-B in FIG. 2;



FIG. 6 shows the printed circuit board including a laminar composite;



FIG. 7 shows the printed circuit board including a laminar composite joined to the upper section forming the capillary gaps;



FIG. 8A shows a view of the upper section forming the capillary gaps;



FIG. 8B shows a further view of the upper section forming the capillary gaps, with the capillary gaps and recess visible;



FIG. 9 shows an inhaler component according to the invention in an alternative embodiment in a view similar to FIG. 2.





DETAILED DESCRIPTION


FIGS. 1A through 1C show multiple views of a first embodiment of an inhaler component according to the invention. The inhaler component in the specific example is designed in the form of an interchangeable part of the inhaler and is capable of being coupled via a snap connection 1 to a reusable inhaler part (not further shown). The inhaler component together with the reusable inhaler part forms the inhaler. The inhaler component consists of a housing 2 and further comprises a mouthpiece 3, by way of which the user of the inhaler draws the vapor-air mixture or/and the condensation aerosol.



FIGS. 2 to 5 provide further information about the internal structure of the inhaler component. Thus a carrier plate 4, which is preferably designed as a printed circuit board, is located in the housing 2. The printed circuit board 4 carries a laminar composite 5. The laminar composite 5 consists of a wick 7 and an electric heating element 6, which are connected to each other in a laminar manner or integrated one into the other. The laminar composite 5 can be formed for example by a metal foil with metal fabric layers sintered on it. The laminar composite 5 can alternatively also consist of an open-pored metal foam. The open-pored capillary structure of the fabric layers sintered onto the metal foil or the metal foam forms the wick 7 and the electrical resistance of the metal forms the heating element 6. Suitable metallic resistance materials are, for example, high-grade steels such as AISI 304 or AISI 316 as well as heat-conducting alloys, in particular NiCr alloys.


The wick 7 and the laminar composite 5 containing it have two end sections 7a and 7b arranged at a distance from each other. The laminar composite 5 is mounted with these end sections on the printed circuit board 4. The laminar composite 5 is furthermore electrically contacted in the region of the end sections 7a and 7b on conductive strips of the printed circuit board 4. The electrical contacting of the laminar composite 5 or the resistance heating element 6 thereof mat, for example, consist of an adhesive joint by means of an electrically conducting adhesive, for example, by means of a silver-containing adhesive based on epoxide. The printed circuit board 4 projects from the outside surface of the housing 2 in the form of two plug contacts 8a and 8b. The two plug contacts 8a and 8b serve to introduce the electrical energy into the inhaler component. The electrical energy is supplied to the electrical resistance heating element 6 via conductive strips of the printed circuit board 4. The printed circuit board 4 is preferably designed in the form of a multiple-layer, so-called multilayer, printed circuit board. The conductive strips are thus present in several layers. The advantages of this special type of printed circuit board have already been described above. The electrical energy is preferably drawn from the reusable inhaler part. For this purpose the reusable inhaler part contains a battery and an electrical control circuit for controlling the energy supply.


An upper section 9 having a recess or depression 10 is placed flat on the printed circuit board 4—see FIGS. 3 to 8B. The recess 10 is shown as a black area in FIG. 8B and has a depth of typically 0.2 mm. The recess 19 faces the printed circuit board 4 and, in conjunction with the surface thereof, forms a capillary gap. The capillary gap is shown diagrammatically in FIG. 2 as a black area and consists of three sections: a first capillary gap 11a, into which the laminar composite 5 or wick 7 with its end section 7a projects; a second capillary gap 11b, into which the laminar composite 5 or wick 7 with its end section 7b projects; and a third capillary gap 11c, which connects the first capillary gap 11a to the second capillary gap 11b. The first capillary gap 11a is connected to the liquid container 12 formed by the housing 2 or arranged in it. The liquid container 12 stores a liquid material 13. The capillary forces in the capillary gap 11a pull the liquid material 13 from the liquid container 12 into the capillary gap 11a. The liquid material 13 first reaches the end section 7a of the laminar composite 5.


There the liquid material 13 moistens the capillary structure of the wick 7, after which the wick 7 can be further infiltrated from this side with liquid material 13. In parallel with this the liquid material 13 flows into the capillary gap 11c and finally arrives by way of the latter at the capillary gap 11b, where in the end section 7b it again moistens the capillary structure of the laminar composite 5 or the wick 7. The wick 7 is thus infiltrated from two sides with the liquid material 13. Since the flow resistance of the capillary gaps is substantially lower than the flow resistance of the wick 7, the infiltration of the wick 7 takes place at almost the same time or symmetrically on both sides. Compared with arrangements with only one-sided supply of the wick 7 (see WO 2010/045671) the infiltration time can be substantially reduced.


After the wick 7 or laminar composite 5 has been completely infiltrated with the liquid material 13, the electrical energy can be supplied to the electrical resistance heating element 6 by way of the conductive strips of the printed circuit board 4 and the liquid material 13 evaporated. TO ensure as far as possible that the conductive strips do not affect the capillary gaps, it is advantageous if the conductive strips are arranged primarily on the back of the printed circuit board 4 and, if necessary, in intermediate layers (multilayer printed circuit board), and the individual conductive strips interconnected appropriately according to the state of the art by means of so-called plated-through holes. The vapor released is mixed in a chamber 14 provided in the housing 2 with the air supplied from the environment through an air intake opening 15 (see FIGS. 3 to 5) and forms the vapor-air mixture or/and condensation aerosol, which can then be transferred to a user via the mouthpiece 3.


In accordance with FIGS. 8A and 8B, the recess 10 in the upper section 9 is bounded in the region of the first capillary gap 11a by a first ventilation groove 16a and in the region of the second capillary gap 11b by a second ventilation groove 16b. In FIG. 2 the ventilation grooves 16a and 16b are represented diagrammatically as broken lines and in FIG. 5 are shown in cross-section. The ventilation groove 16a extends up to the liquid container 12 and ensures that each volume of liquid material 13 removed from the liquid container is replaced by an equivalent volume of air. The ventilation slots 16a and 16b draw in the air via ventilation holes 17a and 17b which are formed by the upper section 9 and which for their part are connected to the chamber 14 via connecting channels 18a and 18b formed by the housing 2. The connecting channels 18a and 18b are shown diagrammatically in FIG. 7 as broken lines. The outlet of the connecting channel 18a into the chamber 14 is shown in FIG. 4.


In principle, all known printed circuit board materials are suitable as the material for the printed circuit board 4, in particular the material types FR1 to FR5. The upper section 9 is added to the printed circuit board 4 by adhesive bonding and likewise consists preferably of a plastic. It is important that the surfaces of the printed circuit board 4 as well as of the upper section 9 are well moistened by the liquid material 13. It is preferable for highly diluted ethanol or/and aqueous solutions to be used as the liquid material 13, in which the actual active substances, aerosol-forming materials, flavorings, as well as, if necessary, further ancillary materials are dissolved or/and emulsified. The wettability as well as the adhesion of the plastics can be substantially improved by surface activation, for example by hydrophilization by means of plasma polymerization (the company Diener electronic GmbH+Co. KG, www.plasma.de).



FIG. 9 shows an alternative embodiment of the inhaler component according to the invention. This embodiment differs from the arrangement according to FIG. 2 essentially in that a second liquid container 12b containing the liquid material 13 is provided, which is coupled or is capable of being coupled to the second capillary gap 11b. If a disturbance of the liquid supply occurs in the first supply path (liquid container 12a and capillary gap 11a), then the laminar composite 5 or the wick 7 thereof can still be adequately supplied with liquid material 13 via the second supply path (liquid container 12b, capillary gap 11b and, if necessary, capillary gap 11c).


Still further components of the inhaler component are briefly described below. Even if these components are not directly relevant to the invention, their description nevertheless contributes to a better understanding of the function of the inhaler component according to the invention as a whole and ensures the workability of the invention still more certainly: as shown in FIG. 2, for example, the liquid container 12 has a valve-like, openable catch 19 on a front face. The openable catch 19 seals the liquid container 12 hermetically off from the exterior in its closed position. Only after opening the openable catch 19 can the liquid material 13 moisten the capillary gap 11a and then, through the action of capillary forces in the capillary gap, penetrate further to the laminar composite 5 and finally infiltrate the wick 7 of the laminar composite 5. The openable catch 19 is opened with the aid of a pin 20 mounted in the housing 2 in an axially adjustable manner (FIG. 3 and FIG. 5). A first end of the pin 20 is directed towards the openable catch 19. A second end extends from the outer surface of the housing 2 like an extension with the catch 19 still closed. The second end of the pin 20 is connected to the reusable inhaler part in a tappet-like operating condition. In the course of the coupling of the inhaler component with the reusable inhaler part the pin 20 is shifted into the housing 2, as a result of which the first end of the pin 20 presses against the openable catch 19. The openable catch 19 has a material weakening around its periphery which is dimensioned in such a way that when pressure is applied by the pin 20 it tears like a pre-determined breaking point over a substantial region of its periphery, but forms a hinge on one side. In this way the openable catch 19 is caused to open like a flap.



FIGS. 2 to 5 further show a condensate-binding device arranged in the chamber 14 consisting of two open-pored, absorbent sponges 21a and 21b. The sponges 21a and 21b absorb into their pores condensate deposits formed from the vapor phase and prevent freely mobile accumulations of condensate from forming in the inhaler component, in particular in the chamber 14, which could impair the function of the inhaler component and, in addition, could represent a risk for the user and the environment, if these accumulations contained drug residues or poisons such as nicotine. The two sponges 21a and 21b to a large extent line the inner walls of the chamber 14, where the sponge 21a extends up to the outlet of the air intake opening 15. In this way the condensate deposits should be prevented from reaching the relatively narrow slot-shaped air intake opening 15, as a result of which the air flow could be obstructed. In an alternative arrangement the air intake opening 15 could also be formed directly by the sponges 21a and 21b. The sponges 21a and 21b preferably consist of fine-pored, highly porous fiber composites. The company Filtrona Richmond Inc., www.filtronaporoustechnologies.com, specializes in the production of such fiber composites, in which both triacetin-bonded cellulose acetate fibers and thermally bonded polyolefin and polyester fibers are used.


As shown in FIGS. 2 to 3, a cooler 22 is provided downstream of the sponges 21a and 21b, which in the specific embodiment is integrated into the preferably interchangeable mouthpiece 3 and consists of a porous wadding 23, through the pores of which the vapor-air mixture or/and condensation aerosol formed flow. The cooler 22 cools the vapor-air mixture or/and condensation aerosol flowing through it and during this withdraws still further condensate from it. In this way the organoleptic characteristics of the vapor-air mixture or/and condensation aerosol taken up by the user can be significantly improved. The wadding 23 can consist for example of a tobacco filling. Such a tobacco filling additionally produces a flavoring of the vapor-air mixture or condensation aerosol flowing through it and is particularly desirable if the liquid material 13 contains nicotine.


Finally, it should be pointed out that the invention is naturally not limited to a laminar composite 5 in accordance with the embodiments just described. The composite could just as well have a linear format.


Furthermore, the composite could also be formed from a plurality of composites or composite sections arranged next to one another, where it is immaterial how the individual composites or composite sections are electrically interconnected to one another. In this connection it should be noted that by means of the multilayer printed circuit board 4 according to the invention both series connections and parallel connections as well as more complex wiring and actuation arrangements can be effected. Finally, the invention also covers devices in which the heating element is arranged separate from the wick. For example, the wick could be formed as a laminate and the heating energy transferred to the wick by electromagnetic waves, in particular radiant heat or microwaves.


LIST OF REFERENCES






    • 1 snap connection


    • 2 housing


    • 3 mouthpiece


    • 4 carrier plate, printed circuit board


    • 5 laminar composite


    • 6 heating element, resistance heating element


    • 7 wick


    • 7
      a, 7b end sections of the wick or composite


    • 8
      a, 8b plug contacts


    • 9 upper section


    • 10 recess


    • 11
      a first capillary gap


    • 11
      b second capillary gap


    • 11
      c third capillary gap


    • 12 liquid container


    • 12
      a first liquid container


    • 12
      b second liquid container


    • 13 liquid material


    • 14 chamber


    • 15 air intake opening


    • 16
      a, 16b ventilation slots


    • 17
      a, 17b ventilation holes


    • 18
      a, 18b connecting channels


    • 19 openable catch


    • 20 pin


    • 21
      a, 21b sponges


    • 22 cooler


    • 23 wadding




Claims
  • 1. An inhaler component comprising: a mouthpiece;a heating element configured to evaporate a portion of a liquid material;a liquid container for retaining the liquid material, the liquid container comprising a valve positioned on an interior face of the inhaler component, wherein the valve seals the liquid material within the liquid container; anda wick configured to automatically supply the liquid material to the heating element.
  • 2. The inhaler component according to claim 1, wherein the valve hermetically seals the liquid within the liquid container.
  • 3. The inhaler component according to claim 1, wherein the valve is located on a front face of the liquid container.
  • 4. The inhaler component according to claim 1, wherein the valve has a material weakening around its periphery.
  • 5. The inhaler component according to claim 1, wherein the valve forms a hinge on one side.
  • 6. The inhaler component according to claim 1, wherein the valve is openable like a flap.
  • 7. The inhaler component according to claim 1, further comprising a gap configured to automatically supply the wick with the liquid material, wherein the gap is a capillary gap and is further configured to automatically resupply the wick with the liquid material after evaporation.
  • 8. The inhaler component according to claim 7, further comprising a laminar composite including the heating element and the wick, and configured such that liquid in the gap is transferred to the wick via an end section of the laminar composite.
  • 9. The inhaler component according to claim 7, wherein the wick includes a first end section, a second end section, and an intermediate section between the first end section and the second end section, the gap configured to supply the liquid material to at least a portion of at least one of the first end section, the second end section, and the intermediate section.
Priority Claims (2)
Number Date Country Kind
A 187/2011 Feb 2011 AT national
A 1095-2011 Jul 2011 AT national
RELATED APPLICATION

This application is a continuation of application Ser. No. 15/997,113, filed Jun. 4, 2018, which in turn is a continuation of application Ser. No. 14/268,909 filed May 2, 2014, now U.S. Pat. No. 10,010,695 issued Jul. 3, 2018, which in turn is a continuation of application Ser. No. 13/984,512, filed Aug. 29, 2013, now U.S. Pat. No. 8,752,545 issued Jun. 17, 2014, which is the national stage entry of International Application No. PCT/AT2012/000017, filed Feb. 2, 2012, which in turn claims priority to Austrian Patent Application No. A187/2011, filed Feb. 11, 2011, and to Austrian Patent Application No. A1095/2011, filed Jul. 27, 2011, each of which is hereby fully incorporated herein by reference.

US Referenced Citations (500)
Number Name Date Kind
228598 Buckley Jun 1880 A
353327 Randolph Nov 1886 A
576653 Bowlby Feb 1897 A
595070 Oldenbusch Dec 1897 A
744074 Hiering Nov 1903 A
799844 Fuller Sep 1905 A
885374 Pohlig Apr 1908 A
1163183 Stoll Dec 1915 A
D53386 Joseph May 1919 S
1436157 Fazio Nov 1922 A
1807936 Saunders Jun 1931 A
1815069 Petro Jul 1931 A
1937120 Julius et al. Nov 1933 A
1937987 Sexton Dec 1933 A
2057353 Whittemore Oct 1936 A
2262318 Fox Nov 1941 A
2371006 Weaver Mar 1945 A
2411946 Max et al. Dec 1946 A
2467923 Allen Apr 1949 A
2483304 Rudolf et al. Sep 1949 A
2522952 Joseph et al. Sep 1950 A
2658368 Siegel Nov 1953 A
2782910 Saul et al. Feb 1957 A
2809634 Hirotada et al. Oct 1957 A
3080624 Weber, III Mar 1963 A
3111396 Ball Nov 1963 A
3165225 Georg et al. Jan 1965 A
3221752 Strahm Dec 1965 A
3402724 Blount et al. Sep 1968 A
3431393 Katsuda et al. Mar 1969 A
3433632 Elbert et al. Mar 1969 A
3490718 Vary et al. Jan 1970 A
3496336 Hingorany et al. Feb 1970 A
3521643 Toth et al. Jul 1970 A
3604428 Moukaddem Sep 1971 A
3722742 Wertz Mar 1973 A
3743136 Chambers Jul 1973 A
3804100 Fariello Apr 1974 A
3861523 Fountain et al. Jan 1975 A
3863803 Valcic Feb 1975 A
3915145 Tomita Oct 1975 A
3964902 Fletcher et al. Jun 1976 A
4009713 Simmons et al. Mar 1977 A
4031906 Knapp Jun 1977 A
4094119 Sullivan Jun 1978 A
4117850 Wood Oct 1978 A
4145001 Weyenberg et al. Mar 1979 A
4161283 Hyman Jul 1979 A
4190412 Nitta Feb 1980 A
4193513 Bull, Jr. Mar 1980 A
4214658 Crow Jul 1980 A
4253476 Sato Mar 1981 A
4449039 Fukazawa et al. May 1984 A
4503851 Braunroth Mar 1985 A
D279508 Bauer et al. Jul 1985 S
4579858 Ferno et al. Apr 1986 A
4588976 Jaselli May 1986 A
4597961 Etscorn Jul 1986 A
4655231 Ray et al. Apr 1987 A
4676237 Wood et al. Jun 1987 A
4677992 Bliznak Jul 1987 A
4733794 Kent Mar 1988 A
4735217 Gerth et al. Apr 1988 A
4736755 Oldham et al. Apr 1988 A
4753383 Focke et al. Jun 1988 A
4793478 Tudor Dec 1988 A
4830028 Lawson et al. May 1989 A
4848374 Chard et al. Jul 1989 A
4858630 Banerjee et al. Aug 1989 A
4878832 Lynch Nov 1989 A
4885129 Leonard et al. Dec 1989 A
4917301 Munteanu Apr 1990 A
4922901 Brooks et al. May 1990 A
4923052 Englebert May 1990 A
4923059 Evers et al. May 1990 A
4924888 Perfetti et al. May 1990 A
4947874 Brooks et al. Aug 1990 A
4947875 Brooks et al. Aug 1990 A
4961438 Korte Oct 1990 A
4978814 Honour Dec 1990 A
5027837 Clearman et al. Jul 1991 A
5031646 Lippiello et al. Jul 1991 A
5044550 Lamm Sep 1991 A
5046514 Bolt Sep 1991 A
5060671 Counts et al. Oct 1991 A
D322687 Tschudin Dec 1991 S
5095647 Zobele et al. Mar 1992 A
5095921 Losee et al. Mar 1992 A
5096921 Bollinger et al. Mar 1992 A
5099861 Clearman et al. Mar 1992 A
5121881 Lembeck Jun 1992 A
5167242 Turner et al. Dec 1992 A
5179966 Losee et al. Jan 1993 A
5234008 Fagg Aug 1993 A
5247947 Clearman et al. Sep 1993 A
5269327 Counts et al. Dec 1993 A
D346878 Gee et al. May 1994 S
5322075 Deevi et al. Jun 1994 A
5357271 Wiklof et al. Oct 1994 A
5388574 Ingebrethsen Feb 1995 A
5390864 Alexander Feb 1995 A
5404890 Gentry et al. Apr 1995 A
5408574 Deevi et al. Apr 1995 A
5448317 Huang Sep 1995 A
5479948 Counts et al. Jan 1996 A
5497792 Prasad et al. Mar 1996 A
5501236 Hill et al. Mar 1996 A
5505214 Collins et al. Apr 1996 A
5530225 Hajaligol Jun 1996 A
5540241 Kim Jul 1996 A
5553791 Alexander Sep 1996 A
5568819 Gentry et al. Oct 1996 A
5626866 Ebert et al. May 1997 A
5636787 Gowhari Jun 1997 A
5649554 Sprinkel et al. Jul 1997 A
5659656 Das Aug 1997 A
5666977 Higgins et al. Sep 1997 A
5692291 Deevi et al. Dec 1997 A
D392069 Rowland Mar 1998 S
5743251 Howell et al. Apr 1998 A
D404201 Wennerstrom Jan 1999 S
5865185 Collins et al. Feb 1999 A
5875968 Miller et al. Mar 1999 A
5878722 Gras et al. Mar 1999 A
5878752 Adams et al. Mar 1999 A
5894841 Voges Apr 1999 A
5896984 Focke et al. Apr 1999 A
D414892 Chen Oct 1999 S
5967312 Jacobs Oct 1999 A
6040560 Fleischhauer et al. Mar 2000 A
6058711 Maciaszek et al. May 2000 A
6065592 Wik May 2000 A
6095505 Miller Aug 2000 A
6119684 Noehl et al. Sep 2000 A
D432263 Issa Oct 2000 S
D434217 Packard et al. Nov 2000 S
D434979 Liu Dec 2000 S
6155268 Takeuchi Dec 2000 A
D436725 Rogers Jan 2001 S
D438003 Minagawa et al. Feb 2001 S
D441133 Emery Apr 2001 S
6275650 Lambert Aug 2001 B1
D449521 Pinkus et al. Oct 2001 S
6321757 McCutcheon Nov 2001 B1
6446793 Layshock Sep 2002 B1
D466012 Baker Nov 2002 S
D470765 Baker Feb 2003 S
D471804 Staples Mar 2003 S
D472012 South Mar 2003 S
6527166 Focke et al. Mar 2003 B1
6530495 Joseph Mar 2003 B1
6561391 Baker May 2003 B1
6652804 Neumann et al. Nov 2003 B1
6681998 Sharpe et al. Jan 2004 B2
6701921 Sprinkel, Jr. et al. Mar 2004 B2
6715605 Manservigi et al. Apr 2004 B1
D493617 Armato Aug 2004 S
6790496 Levander et al. Sep 2004 B1
6799576 Farr Oct 2004 B2
6830046 Blakley et al. Dec 2004 B2
D509732 Staples Sep 2005 S
7100618 Dominguez Sep 2006 B2
7112712 Ancell Sep 2006 B1
D545186 Liebe et al. Jun 2007 S
D549573 Liebe et al. Aug 2007 S
7253282 Dehmlow et al. Aug 2007 B2
7263228 Mori Aug 2007 B2
7263282 Meyer Aug 2007 B2
D550455 Barnhart Sep 2007 S
D566329 Bagaric et al. Apr 2008 S
D566890 Bagaric et al. Apr 2008 S
7389878 Torrico Jun 2008 B1
D573889 Short et al. Jul 2008 S
7400940 McRae et al. Jul 2008 B2
D575451 Jones et al. Aug 2008 S
7455176 Focke, et al. Nov 2008 B2
7540286 Cross et al. Jun 2009 B2
7565969 He Jul 2009 B2
7575002 Demars et al. Aug 2009 B2
D606854 Greenhalgh Dec 2009 S
D610983 Wai Mar 2010 S
D611806 Bried Mar 2010 S
D613903 Wu et al. Apr 2010 S
D613904 Wu et al. Apr 2010 S
D616753 Beam et al. Jun 2010 S
7726320 Robinson et al. Jun 2010 B2
7767698 Warchol et al. Aug 2010 B2
7832410 Hon Nov 2010 B2
D628469 Taylor et al. Dec 2010 S
D631838 Cheng Feb 2011 S
D636257 Bougoulas et al. Apr 2011 S
7992554 Radomski et al. Aug 2011 B2
D649658 Belfance et al. Nov 2011 S
D650738 Leung Dec 2011 S
8079371 Robinson et al. Dec 2011 B2
8113343 Åkerlind Feb 2012 B2
D656094 Wu Mar 2012 S
8156944 Han Apr 2012 B2
D661016 Borges et al. May 2012 S
D671677 Wu Nov 2012 S
D671678 Wu Nov 2012 S
8307834 Palmerino, Sr. et al. Nov 2012 B1
D672642 Supranowicz Dec 2012 S
D674539 Wu Jan 2013 S
8365742 Hon Feb 2013 B2
8375957 Hon Feb 2013 B2
8393331 Hon Mar 2013 B2
8430106 Potter et al. Apr 2013 B2
8448783 Vecchi May 2013 B2
8490628 Hon Jul 2013 B2
8511318 Hon Aug 2013 B2
D693055 Manca et al. Nov 2013 S
D700397 Manca et al. Feb 2014 S
8689805 Hon Apr 2014 B2
8752545 Buchberger Jun 2014 B2
8794245 Scatterday Aug 2014 B1
8833364 Buchberger Sep 2014 B2
D715760 Kim et al. Oct 2014 S
D716267 Kim et al. Oct 2014 S
8869793 Spandorfer et al. Oct 2014 B1
8910640 Sears et al. Dec 2014 B2
D720884 Liu Jan 2015 S
8948578 Buchberger Feb 2015 B2
D723738 Liu Mar 2015 S
8967155 Bundren et al. Mar 2015 B2
8997753 Li et al. Apr 2015 B2
9055617 Thorens et al. Jun 2015 B2
D736460 McKeon et al. Aug 2015 S
D737507 Liu Aug 2015 S
9215895 Bowen et al. Dec 2015 B2
9609894 Abramov et al. Apr 2017 B2
9623205 Buchberger Apr 2017 B2
9730276 Vissa et al. Aug 2017 B2
9943108 Lord Apr 2018 B2
9961939 Reevell May 2018 B2
9974335 Lord May 2018 B2
9974743 Rose et al. May 2018 B2
9986760 Macko et al. Jun 2018 B2
10010695 Buchberger Jul 2018 B2
10045562 Buchberger Aug 2018 B2
10278421 Lord May 2019 B2
10368582 Lord Aug 2019 B2
10765147 Buchberger et al. Sep 2020 B2
11044937 Mcadam et al. Jun 2021 B2
20010004934 Yamamoto et al. Jun 2001 A1
20010042546 Umeda et al. Nov 2001 A1
20020005207 Wrenn et al. Jan 2002 A1
20020016370 Shytle et al. Feb 2002 A1
20020059939 Fox May 2002 A1
20020079309 Cox et al. Jun 2002 A1
20030005620 Ananth et al. Jan 2003 A1
20030049025 Neumann et al. Mar 2003 A1
20030056791 Nichols et al. Mar 2003 A1
20030064340 Pappas Apr 2003 A1
20030079309 Vandenbelt et al. May 2003 A1
20030106551 Sprinkel et al. Jun 2003 A1
20030106552 Sprinkel, Jr. et al. Jun 2003 A1
20030108342 Sherwood et al. Jun 2003 A1
20030108743 Anderson Jun 2003 A1
20030136399 Foley Jul 2003 A1
20030136404 Hindle et al. Jul 2003 A1
20030168057 Snyder et al. Sep 2003 A1
20030176467 Andersson et al. Sep 2003 A1
20030192540 Myrman et al. Oct 2003 A1
20030200964 Blakley et al. Oct 2003 A1
20030202169 Liu Oct 2003 A1
20040025865 Nichols et al. Feb 2004 A1
20040031485 Rustad et al. Feb 2004 A1
20040056651 Marietta Bersana Mar 2004 A1
20040081624 Nguyen et al. Apr 2004 A1
20040129793 Nguyen et al. Jul 2004 A1
20040198818 Quallich et al. Oct 2004 A1
20040210151 Tsukashima et al. Oct 2004 A1
20040213744 Lulla et al. Oct 2004 A1
20040223917 Hindle et al. Nov 2004 A1
20040226568 Takeuchi et al. Nov 2004 A1
20040255941 Nichols et al. Dec 2004 A1
20040261487 Chen Dec 2004 A1
20050009870 Sher et al. Jan 2005 A1
20050016550 Katase Jan 2005 A1
20050063686 Whittle et al. Mar 2005 A1
20050087460 Bruhn et al. Apr 2005 A1
20050133049 Fournier et al. Jun 2005 A1
20050145260 Inagaki et al. Jul 2005 A1
20050155985 Meyer Jul 2005 A1
20050194013 Wright Sep 2005 A1
20050204799 Koch Sep 2005 A1
20050211243 Esser Sep 2005 A1
20050224375 Focke et al. Oct 2005 A1
20050235991 Nichols et al. Oct 2005 A1
20050247436 Hsu Nov 2005 A1
20050268911 Cross et al. Dec 2005 A1
20060018840 Lechuga-Ballesteros et al. Jan 2006 A1
20060073182 Wong et al. Apr 2006 A1
20060078477 Althouse et al. Apr 2006 A1
20060095311 Thompson May 2006 A1
20060137681 Von Hollen et al. Jun 2006 A1
20060180143 Lind et al. Aug 2006 A1
20060196518 Hon Sep 2006 A1
20060283468 Lipowicz Dec 2006 A1
20070014549 Demarest et al. Jan 2007 A1
20070045288 Nelson Mar 2007 A1
20070062548 Horstmann et al. Mar 2007 A1
20070074722 Giroux et al. Apr 2007 A1
20070076067 Hamano et al. Apr 2007 A1
20070082038 Gale et al. Apr 2007 A1
20070102013 Adams et al. May 2007 A1
20070107879 Radomski et al. May 2007 A1
20070134169 Rabinoff Jun 2007 A1
20070135461 Rodgers et al. Jun 2007 A1
20070144514 Yeates et al. Jun 2007 A1
20070155255 Galauner et al. Jul 2007 A1
20070193895 Weiss et al. Aug 2007 A1
20070267031 Hon Nov 2007 A1
20070267032 Shan Nov 2007 A1
20070280972 Zhang et al. Dec 2007 A1
20080017204 Braunshteyn et al. Jan 2008 A1
20080092912 Robinson et al. Apr 2008 A1
20080138423 Gonda Jun 2008 A1
20080149118 Oglesby et al. Jun 2008 A1
20080156326 Belcastro et al. Jul 2008 A1
20080216828 Wensley et al. Sep 2008 A1
20080223382 Zeanah Sep 2008 A1
20080228214 Hoan et al. Sep 2008 A1
20080241255 Rose et al. Oct 2008 A1
20080302375 Andersson et al. Dec 2008 A1
20090009534 Perani et al. Jan 2009 A1
20090023819 Axelsson Jan 2009 A1
20090050139 Watanabe et al. Feb 2009 A1
20090090472 Radomski Apr 2009 A1
20090095311 Han Apr 2009 A1
20090095312 Herbrich et al. Apr 2009 A1
20090133691 Yamada et al. May 2009 A1
20090188490 Han Jul 2009 A1
20090220222 Rabin et al. Sep 2009 A1
20090241947 Bedini et al. Oct 2009 A1
20090266837 Gelardi et al. Oct 2009 A1
20090272379 Thorens et al. Nov 2009 A1
20090288966 Minarelli et al. Nov 2009 A1
20090293892 Williams et al. Dec 2009 A1
20090324206 Young et al. Dec 2009 A1
20100003904 Duescher Jan 2010 A1
20100006113 Urtsev et al. Jan 2010 A1
20100039066 Yuan et al. Feb 2010 A1
20100059070 Potter et al. Mar 2010 A1
20100065653 Wingo et al. Mar 2010 A1
20100083959 Siller Apr 2010 A1
20100108059 Axelsson et al. May 2010 A1
20100116691 Papadimitrakopoulos et al. May 2010 A1
20100181387 Zaffaroni et al. Jul 2010 A1
20100182608 Zribi et al. Jul 2010 A1
20100200006 Robinson et al. Aug 2010 A1
20100211011 Haar Aug 2010 A1
20100236546 Yamada et al. Sep 2010 A1
20100242974 Pan Sep 2010 A1
20100260688 Warchol et al. Oct 2010 A1
20100313901 Fernando et al. Dec 2010 A1
20110011396 Fang Jan 2011 A1
20110036363 Urtsev et al. Feb 2011 A1
20110094523 Thorens et al. Apr 2011 A1
20110126848 Zuber et al. Jun 2011 A1
20110155153 Thorens et al. Jun 2011 A1
20110155718 Greim et al. Jun 2011 A1
20110168194 Hon Jul 2011 A1
20110180433 Rennecamp Jul 2011 A1
20110192914 Ishigami Aug 2011 A1
20110209717 Han Sep 2011 A1
20110226236 Buchberger Sep 2011 A1
20110268809 Brinkley et al. Nov 2011 A1
20110274628 Borschke Nov 2011 A1
20110277757 Terry et al. Nov 2011 A1
20110278189 Terry et al. Nov 2011 A1
20110290267 Yamada et al. Dec 2011 A1
20110297166 Takeuchi et al. Dec 2011 A1
20110303231 Li et al. Dec 2011 A1
20110309157 Yang et al. Dec 2011 A1
20120111347 Hon May 2012 A1
20120145169 Wu Jun 2012 A1
20120180994 Yang et al. Jul 2012 A1
20120180995 Yang et al. Jul 2012 A1
20120199146 Marangos Aug 2012 A1
20120227752 Alelov Sep 2012 A1
20120227753 Newton Sep 2012 A1
20120242974 LaValley et al. Sep 2012 A1
20120255567 Rose et al. Oct 2012 A1
20120260927 Liu Oct 2012 A1
20120285476 Hon Nov 2012 A1
20130074857 Buchberger Mar 2013 A1
20130081623 Buchberger Apr 2013 A1
20130081642 Safari Apr 2013 A1
20130087160 Gherghe Apr 2013 A1
20130098786 Collins Apr 2013 A1
20130112214 Bundren et al. May 2013 A1
20130142782 Rahmel et al. Jun 2013 A1
20130192615 Tucker et al. Aug 2013 A1
20130192619 Tucker et al. Aug 2013 A1
20130192620 Tucker et al. Aug 2013 A1
20130192621 Li et al. Aug 2013 A1
20130192623 Tucker et al. Aug 2013 A1
20130213419 Tucker et al. Aug 2013 A1
20130228191 Newton Sep 2013 A1
20130255702 Griffith, Jr. et al. Oct 2013 A1
20130284192 Peleg et al. Oct 2013 A1
20130298905 Levin et al. Nov 2013 A1
20130306084 Flick Nov 2013 A1
20130319407 Liu Dec 2013 A1
20130319435 Flick Dec 2013 A1
20130333700 Buchberger Dec 2013 A1
20130340779 Liu Dec 2013 A1
20130341218 Liu Dec 2013 A1
20130342157 Liu Dec 2013 A1
20140000638 Sebastian et al. Jan 2014 A1
20140007863 Chen Jan 2014 A1
20140007892 Liu Jan 2014 A1
20140018840 Morgan et al. Jan 2014 A1
20140020697 Liu Jan 2014 A1
20140023824 Masanek et al. Jan 2014 A1
20140048086 Zhanghua Feb 2014 A1
20140053831 Leamon et al. Feb 2014 A1
20140060528 Liu Mar 2014 A1
20140060554 Collett et al. Mar 2014 A1
20140060555 Chang et al. Mar 2014 A1
20140064715 Greim et al. Mar 2014 A1
20140106155 Iandoli Espinosa Apr 2014 A1
20140123989 LaMothe May 2014 A1
20140166027 Fuisz et al. Jun 2014 A1
20140182608 Egoyants et al. Jul 2014 A1
20140196717 Liu Jul 2014 A1
20140196731 Scatterday Jul 2014 A1
20140202454 Buchberger Jul 2014 A1
20140202476 Egoyants et al. Jul 2014 A1
20140209105 Sears et al. Jul 2014 A1
20140216485 Egoyants et al. Aug 2014 A1
20140238396 Buchberger Aug 2014 A1
20140238422 Plunkett et al. Aug 2014 A1
20140238423 Tucker et al. Aug 2014 A1
20140238424 Macko et al. Aug 2014 A1
20140253144 Novak et al. Sep 2014 A1
20140261486 Potter et al. Sep 2014 A1
20140261487 Chapman et al. Sep 2014 A1
20140261488 Tucker Sep 2014 A1
20140261489 Cadieux et al. Sep 2014 A1
20140261490 Kane Sep 2014 A1
20140261493 Smith et al. Sep 2014 A1
20140261495 Novak, III et al. Sep 2014 A1
20140270726 Egoyants et al. Sep 2014 A1
20140270729 Depiano et al. Sep 2014 A1
20140270730 DePiano et al. Sep 2014 A1
20140283825 Buchberger Sep 2014 A1
20140286630 Buchberger Sep 2014 A1
20140299125 Buchberger Oct 2014 A1
20140299141 Flick Oct 2014 A1
20140305431 Holley et al. Oct 2014 A1
20140332019 Liu Nov 2014 A1
20140338680 Abramov et al. Nov 2014 A1
20140345635 Rabinowitz et al. Nov 2014 A1
20150020823 Lipowicz et al. Jan 2015 A1
20150101626 Li et al. Apr 2015 A1
20150114411 Buchberger Apr 2015 A1
20150128964 Bundren et al. May 2015 A1
20150128971 Verleur et al. May 2015 A1
20150136756 Vissa et al. May 2015 A1
20150157055 Lord Jun 2015 A1
20150164143 Maas Jun 2015 A1
20150181934 Lyubomirskiy et al. Jul 2015 A1
20150181937 Dubief et al. Jul 2015 A1
20150196058 Lord Jul 2015 A1
20150201675 Lord Jul 2015 A1
20150208728 Lord Jul 2015 A1
20150250232 Hon Sep 2015 A1
20150313275 Anderson et al. Nov 2015 A1
20160021934 Cadieux et al. Jan 2016 A1
20160073693 Reevell Mar 2016 A1
20160101909 Schennum et al. Apr 2016 A1
20160106154 Lord Apr 2016 A1
20160106155 Reevell Apr 2016 A1
20160120218 Schennum et al. May 2016 A1
20160150825 Mironov et al. Jun 2016 A1
20160278163 Chen Sep 2016 A1
20160353804 Lord Dec 2016 A1
20170006916 Liu Jan 2017 A1
20170027225 Buchberger et al. Feb 2017 A1
20170042245 Buchberger et al. Feb 2017 A1
20170135401 Dickens May 2017 A1
20170143038 Dickens May 2017 A1
20170188629 Dickens et al. Jul 2017 A1
20170188630 Buchberger Jul 2017 A1
20170197043 Buchberger Jul 2017 A1
20170197044 Buchberger Jul 2017 A1
20170197046 Buchberger Jul 2017 A1
20170215476 Dickens et al. Aug 2017 A1
20170224014 Fraser Aug 2017 A1
20170231284 Newns Aug 2017 A1
20170251725 Buchberger et al. Sep 2017 A1
20180192705 Lord Jul 2018 A1
20180235284 Lord Aug 2018 A1
20190254350 Lord Aug 2019 A1
20190289920 Lord Sep 2019 A1
20210146067 Buchberger May 2021 A1
20210196919 Potharaju Jul 2021 A1
Foreign Referenced Citations (482)
Number Date Country
16602008 Oct 2008 AT
507187 Mar 2010 AT
507187 Mar 2010 AT
507188 Mar 2010 AT
508244 Dec 2010 AT
510405 Apr 2012 AT
510504 Apr 2012 AT
6391373 Jun 1975 AU
6393173 Jun 1975 AU
2015341516 Dec 2017 AU
2015341517 Jan 2018 AU
2015255045 Mar 2018 AU
2015359102 Jun 2018 AU
2017256084 Sep 2020 AU
6402132 Jul 1986 BR
112017009252 Jan 2018 BR
2309376 Nov 2000 CA
2446102 Apr 2004 CA
2824970 Aug 2012 CA
2909967 Nov 2014 CA
698603 Sep 2009 CH
199400288 Aug 1995 CL
199900377 Mar 1999 CL
2004000365 Feb 2005 CL
2012000958 Jan 2013 CL
2013002357 Nov 2013 CL
2017001108 Jan 2018 CL
2017001137 Jan 2018 CL
86103434 Nov 1986 CN
1039530 Feb 1990 CN
2092880 Jan 1992 CN
1102647 May 1995 CN
2220168 Feb 1996 CN
1126425 Jul 1996 CN
1205849 Jan 1999 CN
1312730 Sep 2001 CN
1329567 Jan 2002 CN
1333657 Jan 2002 CN
1337903 Feb 2002 CN
2485265 Apr 2002 CN
1530041 Sep 2004 CN
2660914 Dec 2004 CN
1607911 Apr 2005 CN
1607950 Apr 2005 CN
2719043 Aug 2005 CN
1694765 Nov 2005 CN
1703279 Nov 2005 CN
2754386 Feb 2006 CN
2777995 May 2006 CN
1286409 Nov 2006 CN
2904674 May 2007 CN
200966824 Oct 2007 CN
101115901 Jan 2008 CN
201023852 Feb 2008 CN
201067079 Jun 2008 CN
201079011 Jul 2008 CN
101437496 May 2009 CN
201238609 May 2009 CN
201240612 May 2009 CN
101557728 Oct 2009 CN
201375023 Jan 2010 CN
101648041 Feb 2010 CN
201430913 Mar 2010 CN
101843368 Sep 2010 CN
201592850 Sep 2010 CN
101878958 Nov 2010 CN
101925309 Dec 2010 CN
201657770 Dec 2010 CN
101951796 Jan 2011 CN
102014677 Apr 2011 CN
201830900 May 2011 CN
201860753 Jun 2011 CN
102264249 Nov 2011 CN
102264420 Nov 2011 CN
102326869 Jan 2012 CN
202122096 Jan 2012 CN
102389166 Mar 2012 CN
202172846 Mar 2012 CN
102655773 Sep 2012 CN
102753047 Oct 2012 CN
102883766 Jan 2013 CN
202722498 Feb 2013 CN
202750708 Feb 2013 CN
103052380 Apr 2013 CN
103338664 Oct 2013 CN
103491958 Jan 2014 CN
103960782 Aug 2014 CN
203986095 Dec 2014 CN
204048047 Dec 2014 CN
104602553 May 2015 CN
204317492 May 2015 CN
104684422 Jun 2015 CN
204598339 Aug 2015 CN
104983079 Oct 2015 CN
105310114 Feb 2016 CN
105394816 Mar 2016 CN
205106385 Mar 2016 CN
106102863 Nov 2016 CN
106998820 Oct 2019 CN
594585 Mar 1934 DE
1950439 Apr 1971 DE
2653133 May 1978 DE
2940797 Apr 1981 DE
3148335 Jul 1983 DE
3218760 Dec 1983 DE
3936687 May 1990 DE
29719509 Jan 1998 DE
19630619 Feb 1998 DE
19654945 Mar 1998 DE
29803260 Jul 1998 DE
10330681 Jun 2004 DE
202006013439 Oct 2006 DE
102006004484 Aug 2007 DE
202013100606 Feb 2013 DE
009116 Oct 2007 EA
019736 May 2014 EA
022685 Feb 2016 EA
201692191 Mar 2017 EA
0280262 Aug 1988 EP
0283672 Sep 1988 EP
0289342 Nov 1988 EP
0290911 Nov 1988 EP
0295122 Dec 1988 EP
0358002 Mar 1990 EP
0358114 Mar 1990 EP
0444553 Sep 1991 EP
0488488 Jun 1992 EP
0520231 Dec 1992 EP
0845220 Jun 1998 EP
0847220 Jun 1998 EP
0893071 Jan 1999 EP
0893171 Jan 1999 EP
1166814 Jan 2002 EP
1166847 Jan 2002 EP
1468618 Oct 2004 EP
1509227 Mar 2005 EP
1618803 Jan 2006 EP
1736065 Dec 2006 EP
1757921 Feb 2007 EP
1772166 Apr 2007 EP
1772199 Apr 2007 EP
1820748 Aug 2007 EP
1847671 Oct 2007 EP
1950439 Jul 2008 EP
2018886 Jan 2009 EP
2022349 Feb 2009 EP
2022350 Feb 2009 EP
1509227 Oct 2009 EP
2113178 Nov 2009 EP
2234891 Oct 2010 EP
2340729 Jul 2011 EP
2358223 Aug 2011 EP
2358418 Aug 2011 EP
2404515 Jan 2012 EP
2468116 Jun 2012 EP
2468118 Jun 2012 EP
2477607 Jul 2012 EP
2698070 Feb 2014 EP
2762019 Aug 2014 EP
2779786 Sep 2014 EP
2785208 Oct 2014 EP
2801273 Nov 2014 EP
2835062 Feb 2015 EP
2871985 May 2015 EP
2907397 Aug 2015 EP
2967144 Jan 2016 EP
2993999 Mar 2016 EP
3021699 May 2016 EP
3073846 Oct 2016 EP
3076805 Oct 2016 EP
3145348 Mar 2017 EP
2907397 Sep 2017 EP
3284500 Feb 2018 EP
3117860 Jan 2019 EP
3214957 Feb 2019 EP
3229621 Jan 2020 EP
3491941 Aug 2020 EP
3738632 Feb 2022 EP
472030 Nov 1914 FR
960469 Apr 1950 FR
1292446 May 1962 FR
190903566 Jun 1909 GB
190930472 Dec 1909 GB
191100628 Nov 1911 GB
25575 Mar 1912 GB
191311086 Sep 1913 GB
110216 Oct 1917 GB
111454 Nov 1917 GB
120016 Oct 1918 GB
160493 Mar 1921 GB
163124 May 1921 GB
215992 May 1924 GB
220229 Aug 1924 GB
268967 Apr 1927 GB
402064 Nov 1933 GB
438750 Nov 1935 GB
507955 Jun 1939 GB
544329 Apr 1942 GB
565574 Nov 1944 GB
611596 Nov 1948 GB
626888 Jul 1949 GB
871869 Jul 1961 GB
1313525 Apr 1973 GB
2133691 Aug 1984 GB
1046183 Jul 1988 GB
2275464 Aug 1994 GB
2068034 Nov 1997 GB
2369108 May 2002 GB
4000273 Dec 2006 GB
4006615 Oct 2008 GB
2504075 Jan 2014 GB
2513635 Nov 2014 GB
1196511 Dec 2014 HK
1226611 Oct 2017 HK
S20060065 Oct 2006 IE
0351KOL2006 Jul 2007 IN
S5289386 Jul 1977 JP
S5752456 Mar 1982 JP
S57140354 Aug 1982 JP
S59106340 Jun 1984 JP
S59135878 Aug 1984 JP
S6121542 Jan 1986 JP
S6121542 May 1986 JP
S6196763 May 1986 JP
S6196765 May 1986 JP
H01104153 Apr 1989 JP
H01117775 May 1989 JP
H02124081 May 1990 JP
H02124082 May 1990 JP
H0548944 Feb 1993 JP
H05103836 Apr 1993 JP
H05309136 Nov 1993 JP
3003543 Oct 1994 JP
H06303837 Nov 1994 JP
H06315366 Nov 1994 JP
H07147965 Jun 1995 JP
H08299862 Nov 1996 JP
H08511176 Nov 1996 JP
H1189551 Apr 1999 JP
H11503912 Apr 1999 JP
H11514018 Nov 1999 JP
H11514081 Nov 1999 JP
3003543 Jan 2000 JP
2001502542 Feb 2001 JP
2001248842 Sep 2001 JP
2002527153 Aug 2002 JP
2003024036 Jan 2003 JP
3093201 Apr 2003 JP
2003226577 Aug 2003 JP
2004097617 Apr 2004 JP
2004512907 Apr 2004 JP
2004332069 Nov 2004 JP
2005013092 Jan 2005 JP
2005034021 Feb 2005 JP
2005514991 May 2005 JP
2005138773 Jun 2005 JP
2005524067 Aug 2005 JP
2005533770 Nov 2005 JP
2005537918 Dec 2005 JP
2005537919 Dec 2005 JP
2005538149 Dec 2005 JP
2005538159 Dec 2005 JP
2006305336 Nov 2006 JP
2007057532 Mar 2007 JP
2007097787 Apr 2007 JP
2007512880 May 2007 JP
2007297124 Nov 2007 JP
2008501406 Jan 2008 JP
2008544834 Dec 2008 JP
2009509523 Mar 2009 JP
2009526714 Jul 2009 JP
2009529871 Aug 2009 JP
2009537119 Oct 2009 JP
2010080261 Apr 2010 JP
2011087569 May 2011 JP
2011515093 May 2011 JP
2011518567 Jun 2011 JP
2012013247 Jan 2012 JP
2012026933 Feb 2012 JP
2012029633 Feb 2012 JP
2012057859 Mar 2012 JP
2012506263 Mar 2012 JP
2012223190 Nov 2012 JP
2012249854 Dec 2012 JP
2013516159 May 2013 JP
2013521075 Jun 2013 JP
2013545473 Dec 2013 JP
2014501107 Jan 2014 JP
2014511175 May 2014 JP
2014516624 Jul 2014 JP
2014520542 Aug 2014 JP
2014524313 Sep 2014 JP
2014525251 Sep 2014 JP
2015500025 Jan 2015 JP
2015505476 Feb 2015 JP
2015506182 Mar 2015 JP
2015513970 May 2015 JP
2015521847 Aug 2015 JP
2016510994 Apr 2016 JP
2016520061 Jul 2016 JP
2017518033 Jul 2017 JP
2017522868 Aug 2017 JP
2017525348 Sep 2017 JP
6507248 Apr 2019 JP
920017172 Sep 1992 KR
100244670 Feb 2000 KR
20050037919 Apr 2005 KR
20090008142 Aug 2009 KR
20100006995 Jul 2010 KR
20110006928 Jul 2011 KR
20120025569 Mar 2012 KR
20120070731 Jul 2012 KR
20120104183 Sep 2012 KR
20130004985 Jan 2013 KR
20130006714 Jan 2013 KR
20130006714 Nov 2013 KR
200470732 Jan 2014 KR
20140128449 Nov 2014 KR
101955000 Mar 2019 KR
102148901 Aug 2020 KR
6617184 Jun 1967 NL
12017500957 Oct 2017 PH
2311859 Dec 2007 RU
2328192 Jul 2008 RU
2330314 Jul 2008 RU
2333014 Sep 2008 RU
2336001 Oct 2008 RU
2360583 Jul 2009 RU
89927 Dec 2009 RU
94815 Jun 2010 RU
103281 Apr 2011 RU
115629 May 2012 RU
121706 Nov 2012 RU
122000 Nov 2012 RU
124120 Jan 2013 RU
2476331 Feb 2013 RU
132318 Sep 2013 RU
2509516 Mar 2014 RU
88052 Sep 2009 UA
89752 Mar 2010 UA
67598 Feb 2012 UA
78167 Mar 2013 UA
9503050 Feb 1995 WO
WO-9527412 Oct 1995 WO
WO-9632854 Oct 1996 WO
WO-9748293 Dec 1997 WO
WO-9817131 Apr 1998 WO
WO-0009188 Feb 2000 WO
WO-0021598 Apr 2000 WO
WO-0028842 May 2000 WO
WO-0050111 Aug 2000 WO
0102040 Jan 2001 WO
0122907 Apr 2001 WO
WO-02051468 Jul 2002 WO
WO-02058747 Aug 2002 WO
WO-02060769 Aug 2002 WO
WO-03005045 Jan 2003 WO
WO-03028409 Apr 2003 WO
WO-03050405 Jun 2003 WO
03055486 Jul 2003 WO
03059424 Jul 2003 WO
WO-03083283 Oct 2003 WO
WO-03101454 Dec 2003 WO
WO-2004022128 Mar 2004 WO
WO-2004022242 Mar 2004 WO
WO-2004022243 Mar 2004 WO
2004029050 Apr 2004 WO
2004065348 Aug 2004 WO
2004076289 Sep 2004 WO
2004076412 Sep 2004 WO
2004076289 Dec 2004 WO
2005004989 Jan 2005 WO
2005039531 May 2005 WO
2005075452 Aug 2005 WO
2005089728 Sep 2005 WO
2005108389 Nov 2005 WO
WO-2005106350 Nov 2005 WO
2005120614 Dec 2005 WO
2006004646 Jan 2006 WO
2006008108 Jan 2006 WO
2006034833 Apr 2006 WO
2006073366 Jul 2006 WO
WO-2006082571 Aug 2006 WO
2007002597 Jan 2007 WO
2007038215 Apr 2007 WO
WO-2007040941 Apr 2007 WO
WO-2007042941 Apr 2007 WO
WO-2007108877 Sep 2007 WO
WO-2007131448 Nov 2007 WO
WO-2007131449 Nov 2007 WO
WO-2007141668 Dec 2007 WO
WO-2008006048 Jan 2008 WO
2008015918 Feb 2008 WO
WO-2008038144 Apr 2008 WO
2008073942 Jun 2008 WO
WO-2008104870 Sep 2008 WO
WO-2009001085 Dec 2008 WO
2009007767 Jan 2009 WO
2009007768 Jan 2009 WO
2009007769 Jan 2009 WO
2009007770 Jan 2009 WO
2009007771 Jan 2009 WO
WO-2009015410 Feb 2009 WO
2009079641 Jun 2009 WO
WO2009092419 Jul 2009 WO
WO-2009092862 Jul 2009 WO
WO-2009092419 Sep 2009 WO
WO-2009118085 Oct 2009 WO
2009135729 Nov 2009 WO
WO-2009132793 Nov 2009 WO
WO-2010045670 Apr 2010 WO
WO-2010045671 Apr 2010 WO
2011034723 Mar 2011 WO
2011045609 Apr 2011 WO
WO-2011050943 May 2011 WO
WO-2011050964 May 2011 WO
WO-2011079932 Jul 2011 WO
WO-2011109849 Sep 2011 WO
2011139684 Nov 2011 WO
2011139811 Nov 2011 WO
WO-2011137453 Nov 2011 WO
WO-2012025496 Mar 2012 WO
WO-2012065310 May 2012 WO
WO-2012065754 May 2012 WO
WO-2012085203 Jun 2012 WO
WO-2012085207 Jun 2012 WO
2012110819 Aug 2012 WO
WO-2012106739 Aug 2012 WO
WO-2012114082 Aug 2012 WO
2012134380 Oct 2012 WO
2012142293 Oct 2012 WO
WO-2013013808 Jan 2013 WO
WO-2013025921 Feb 2013 WO
2013034452 Mar 2013 WO
WO-2013034453 Mar 2013 WO
WO-2013034460 Mar 2013 WO
WO-2013045942 Apr 2013 WO
WO-2013057185 Apr 2013 WO
WO-2013082173 Jun 2013 WO
WO-2013083631 Jun 2013 WO
WO-2013098395 Jul 2013 WO
2013110210 Aug 2013 WO
2013116561 Aug 2013 WO
WO-2013116558 Aug 2013 WO
WO-2013116571 Aug 2013 WO
WO-2013116572 Aug 2013 WO
WO-2013142671 Sep 2013 WO
WO-2013152873 Oct 2013 WO
WO-2013178769 Dec 2013 WO
WO-2013189050 Dec 2013 WO
WO-2013189052 Dec 2013 WO
2014004648 Jan 2014 WO
WO-2014005275 Jan 2014 WO
WO-2014012906 Jan 2014 WO
WO2014012907 Jan 2014 WO
WO-2014015463 Jan 2014 WO
WO-2014061477 Apr 2014 WO
WO-2014071329 May 2014 WO
WO-2014130695 Aug 2014 WO
2014150245 Sep 2014 WO
2014151434 Sep 2014 WO
WO-2014140320 Sep 2014 WO
WO-2014150131 Sep 2014 WO
2014159240 Oct 2014 WO
2014159250 Oct 2014 WO
2014177859 Nov 2014 WO
2014182736 Nov 2014 WO
2014190079 Nov 2014 WO
2015009862 Jan 2015 WO
2015054885 Apr 2015 WO
2015084544 Jun 2015 WO
2015091258 Jun 2015 WO
WO-2015114327 Aug 2015 WO
WO-2015114328 Aug 2015 WO
2015149404 Oct 2015 WO
2015167629 Nov 2015 WO
2015179292 Nov 2015 WO
WO-2015165812 Nov 2015 WO
2015189623 Dec 2015 WO
2015198049 Dec 2015 WO
2016071705 May 2016 WO
2016071706 May 2016 WO
Non-Patent Literature Citations (351)
Entry
Aerosols, “Pulmonary Pharmacology: Delivery Devices and Medications,” Sep. 6, 2017, available at www.cdeu.org/cecourses/z98207/ch4.html, 2 pages.
Application and File History for U.S. Appl. No. 13/125,343, filed Apr. 21, 2011, inventor Buchberger.
Application and File History for U.S. Appl. No. 13/984,512, filed Aug. 29, 2013, inventor Buchberger.
Application and File History for U.S. Appl. No. 14/235,210, filed Mar. 4, 2014, inventor Buchberger, 504 pages.
Application and File History for U.S. Appl. No. 14/268,909, filed May 2, 2014, inventor Buchberger.
Application and File History for U.S. Appl. No. 14/296,803, filed Jun. 5, 2014, inventor Buchberger, 627 pages.
Application and File History for U.S. Appl. No. 14/306,831, filed Jun. 17, 2014, inventor Buchberger.
Application and File History for U.S. Appl. No. 14/353,256, filed Apr. 21, 2014, inventor Buchberger, 375 pages.
Application and File History for U.S. Appl. No. 14/594,065, filed Jan. 9, 2015, Inventor Buchberger, 302 pages.
Application and File History for U.S. Appl. No. 14/787,946, filed Oct. 29, 2015, inventor Lord, 228 pages.
Application and File History for U.S. Appl. No. 14/888,514, filed Nov. 2, 2015, inventor Reevell, 188 pages.
Application and File History for U.S. Appl. No. 14/888,517, filed Nov. 2, 2015, Inventor Reevell, 136 pages.
Application and File History for U.S. Appl. No. 15/307,095, filed Oct. 27, 2016, inventor Buchberger, 288 pages.
Application and File History for U.S. Appl. No. 15/454,156, filed Mar. 9, 2017, inventor Buchberger, 61 pages.
Application and File History for U.S. Appl. No. 15/470,078, filed Mar. 27, 2017, inventor Buchberger, 392 pages.
Application and File History for U.S. Appl. No. 15/470,089, filed Mar. 27, 2017, inventor Buchberger, 558 pages.
Application and File History for U.S. Appl. No. 15/470,095, filed Mar. 27, 2017, inventor Buchberger, 351 pages.
Application and File History for U.S. Appl. No. 15/997,113, filed Jun. 4, 2018, inventor Buchberger.
Application and File History for U.S. Appl. No. 16/096,554, filed Oct. 25, 2018, Inventor Fraser.
Company Filtrona Richmond Inc., www.filtronaporoustechnologies.com, Nov. 19, 2018, 1 page.
Decision on Appeal, U.S. Appl. No. 14/306,831, mailing date Mar. 26, 2020, 6 pages.
Decision to Grant a Patent dated May 22, 2018 for Japanese Application No. 2016-134648, 5 pages.
Decision to Grant dated Feb. 5, 2018 for Ukraine Application No. 201607243, 6 pages.
Decision to Grant dated Apr. 11, 2016 for Russian Application No. 2015100321, 8 pages (No translation available).
Decision to Grant dated Jun. 23, 2016 for Ukrainian Application No. 201500198, 6 pages (No translation available).
Decision to Grant dated Apr. 27, 2017 for Russian Application No. 2015146845, 8 pages.
Decision to Grant for Australian Application No. 2017105898, dated Mar. 16, 2018, 12 pages.
Decision to Grant for Great Britain Application No. GB1405720.2, dated Sep. 26, 2017, 2 pages.
Decision to Grant for Russian Application No. 120267, dated Oct. 26, 2016, 7 pages.
Decision to Grant dated Apr. 1, 2014 for Russian Application No. 2011120430, 16 pages.
Decision to Grant dated Aug. 5, 2014 for Japanese Application No. 2011-532464, 6 pages.
Diener Electronic, “Plasma Polymerization,” The company Diener electronic GmbH+Co. KG, Retrieved on Oct. 17, 2017, 19 pages.
Dunn P.D., et al., “Heat Pipes,” Fourth Edition, Pergamon, ISBN0080419038, 1994, 14 pages.
ECF, “Welcome to the World's Largest E-Cigarette Website: The Voice of Vaping since 2007,” Oct. 2011, Nichrome or Kanthal Specs for Purchasing, retrieved on Apr. 19, 2020, 6 pages.
Examination Report for Great Britain Application No. GB1405720.2, dated Jun. 27, 2017, 3 pages.
Examination Report dated Nov. 20 for Australian Application No. 2017256084, 3 pages.
Examination Report dated Dec. 15, 2017, for Australian Application No. 201512626, 3 pages.
Extended European Search Report for Application No. 15178588, dated Apr. 14, 2016, 2 pages.
Extended European Search Report for Application No. 16166656, dated Oct. 11, 2016, 9 pages.
Extended European Search Report for Application No. 17189951.1, dated Jan. 4, 2018, 11 pages.
Extended European Search Report for Application No. 18205608.5, dated Jul. 12, 2019, 7 pages.
Extended European Search Report for Application No. EP17197150.5, dated Mar. 1, 2018, 6 pages.
Extended European Search Report for Application No. 16151458.3, dated Jul. 11, 2016, 8 pages.
Extended European Search Report for Application No. 19196432.9, dated Dec. 9, 2019, 14 pages.
Extended European Search Report for European Application No. 15178588, dated Apr. 22, 2016, 4 pages.
First Office Action for Chinese Application No. 201480031926.5 dated Apr. 21, 2017, 12 pages.
First Office Action dated Dec. 3, 2012 for Chinese Application No. 200980152395.4, 16 pages.
Hegbom T., “Integrating Electrical Heating Elements in Appliance Design,” resulting in interlocutory decision dated Aug. 7, 2019, 4 pages.
Hong Kong Publication, Application No. 14110165.2, published on Dec. 19, 2014, 1 page.
Hong Kong Publication, Application No. 16113324.2, published on Oct. 6, 2017, 1 page.
Iatty, “An Idea of the Iatty, Welcome to the World's Largest E-Cigarette Website: The Voice of Vaping since 2007,” retrieved on Dec. 17, 2019, p. 23, Post 443 and 445, 7 pages.
Iatty, “An Idea of the Iatty, Welcome to the World's Largest E-Cigarette Website: The Voice of Vaping since 2007,” retrieved on Dec. 17, 2019, p. 24, Post 467, 6 pages.
Iatty, “An Idea of the Iatty, Welcome to the World's Largest E-Cigarette Website: The Voice of Vaping since 2007,” retrieved on Dec. 17, 2019, p. 37, Post 727, 6 pages.
Iatty, “An Idea of the Iatty, Welcome to the World's Largest E-Cigarette Website: The Voice of Vaping since 2007,” retrieved on Dec. 17, 2019, Page, Post 1, 7 pages.
“Integrating Electrical Heating Elements in Product Design,” Metallic Resistance Heating Wire, Chapter 1, Section 1.1 to 1.3.2, resulting in interlocutory decision dated Aug. 7, 2019, 6 pages.
“Integrating Electrical Heating Elements in Product Design,” Metallic Resistance Heating Wire, Chapter 1, Section 1.4, resulting in interlocutory decision dated Aug. 7, 2019, 1 page.
“Integrating Electrical Heating Elements in Product Design,” Metallic Resistance Heating Wire, resulting in interlocutory decision dated Aug. 7, 2019, 8 pages.
International Preliminary Report on Patentability for Application No. PCT/AT2009/000413, dated May 5, 2011, 7 pages.
International Preliminary Report on Patentability for Application No. PCT/AT2009/000414, dated Apr. 26, 2011, 7 pages.
International Preliminary Report on Patentability for Application No. PCT/AT2012/000017, dated Aug. 13, 2013, 5 pages.
International Preliminary Report on Patentability for Application No. PCT/EP2012/003103, dated Feb. 6, 2014, 7 pages.
International Preliminary Report on Patentability for Application No. PCT/EP2012/070647, dated Apr. 22, 2014, 8 pages.
International Preliminary Report on Patentability for Application No. PCT/GB2014/051332, dated Nov. 12, 2015, 7 pages.
International Preliminary Report on Patentability for Application No. PCT/GB2014/051333, dated Aug. 5, 2015, 12 pages.
International Preliminary Report on Patentability for Application No. PCT/GB2014/051334, dated Nov. 12, 2015, 7 pages.
International Preliminary Report on Patentability for Application No. PCT/GB2014/051688, dated Dec. 17, 2015, 6 pages.
International Preliminary Report on Patentability for Application No. PCT/GB2015/050195, dated May 13, 2016, 17 pages.
International Preliminary Report on Patentability for Application No. PCT/GB2015/051213, dated Jul. 14, 2016, 20 pages.
International Preliminary Report on Patentability for Application No. PCT/GB2015/053445, dated Jan. 24, 2017, 19 pages.
International Preliminary Report on Patentability for Application No. PCT/GB2017/051139, dated Aug. 6, 2018, 7 pages.
International Preliminary Report on Patentability dated Sep. 9, 2014 for Application No. PCT/EP2013/64922, filed Jul. 15, 2013, 10 pages.
International Search Report and Written Opinion for Application No. PCT/AT2012/000017, dated Jul. 3, 2012, 6 pages.
International Search Report and Written Opinion for Application No. PCT/EP2012/003103, dated Nov. 26, 2012, 6 pages.
International Search Report and Written Opinion for Application No. PCT/EP2012/070647, dated Feb. 6, 2013, 9 pages.
International Search Report and Written Opinion for Application No. PCT/GB2014/051332, dated Jul. 21, 2014, 8 pages.
International Search Report and Written Opinion for Application No. PCT/GB2014/051333, dated Jul. 17, 2014, 10 pages.
International Search Report and Written Opinion for Application No. PCT/GB2014/051334, dated Jul. 21, 2014, 8 pages.
International Search Report and Written Opinion for Application No. PCT/GB2015/053445, dated Apr. 18, 2016, 21 pages.
International Search Report and Written Opinion for Application No. PCT/GB2017/051139, dated Aug. 9, 2017, 14 pages.
International Search Report and Written Opinion dated Oct. 11, 2013 for Application No. PCT/EP2013/064922, filed Jul. 15, 2013, 6 pages.
International Search Report for App No. PCT/GB2015/050195, dated Sep. 2, 2015, 4 pages.
International Search Report for Application No. PCT/AT2009/000413, dated Jan. 25, 2010, 3 pages.
International Search Report for Application No. PCT/AT2009/000414, dated Jan. 26, 2010, 2 pages.
International Search Report for Application No. PCT/GB2014/051633, dated Dec. 4, 2014, 7 pages.
International Search Report for Application No. PCT/GB2014/051688, dated Aug. 26, 2014, 4 pages.
International Search Report for Application No. PCT/GB2015/051213, dated Jul. 16, 2015, 5 pages.
Kynol, “Standard Specifications of Kynol™ Activated Carbon Fiber Products,” Sep. 19, 2013, 2 pages.
Iatty, “E-Cigarette Forum,” p. 10, May 2011, commentary by Imeothanasis and Iorderos33, retrieved on Feb. 11, 2019, 8 pages.
Notice of Allowance dated Oct. 18, 2019 for Korean Application No. 1020167018457, 2 pages (with translation—3 pages).
Notice of Allowance dated May 30, 2017 for Korean Application No. 1020157001277, 4 pages (No translation available).
Notice of Allowance dated Jun. 27, 2018 for Korean Application No. 1020167020977, 3 pages.
Notice of Opposition Letter from EPO Opposition against the European Application No. 2358418, mailed Mar. 1, 2017, 60 pages.
Notice of Opposition mailed Oct. 30, 2019 for European Application No. 16166656.5, 39 pages.
Notice of Reasons for Rejection for Japanese Application No. 2020-121265, dated Jul. 20, 2021, 8 pages.
Notice of Reasons for Rejection dated Oct. 15, 2013 for Japanese Application No. 2011532464, 6 pages.
Notice of Reasons for Rejection dated May 23, 2017 for Japanese Application No. 2016134648, 18 pages.
Notice of Reasons for Rejection dated May 31, 2016 for Japanese Application No. 2015-137361, 6 pages.
Notice of Reasons for Rejection dated Oct. 7, 2013 for Japanese Application No. 2011532464, 6 pages.
Notice of Reasons for Rejection dated Sep. 8, 2015 for Japanese Application No. 2014179732, 5 pages.
Notice of Reasons for Revocation dated Apr. 17, 2017 for Japanese Patent No. 5960358, with English translation, 12 pages.
Notification of Transmittal of IPRP for International Application No. PCT/GB2014/051633 dated Oct. 23, 2015, 9 pages.
Notification to Grant Patent Right for Invention dated Oct. 25, 2018 for Chinese Application No. 201610086101.4, 2 pages.
Office Action and Search Report dated Feb. 28, 2019 for Japanese Application No. 2018-088088, 25 pages.
Office Action dated Sep. 3, 2014, for Russian Application No. 2013504605, 7 pages.
Office Action dated Jul. 2, 2020 for Chinese Application No. 201780020023.0 filed Sep. 25, 2018, 22 pages.
Office Action dated Nov. 21, 2017 for Russian Application No. 2016142584, 8 pages.
Office Action dated Nov. 22, 2016 for Canadian Application No. 2878951, 3 pages.
Office Action dated Sep. 22, 2017 for Russian Application No. 2015146847, 11 pages.
Office Action dated Nov. 23, 2018 for Korean Application No. 1020167018457, 6 pages (12 pages with translation).
Office Action dated Apr. 25, 2017 for Japanese Application No. 2016123816, 2 pages (No translation available).
Office Action dated May 12, 2017 for Korean Application No. 10-20157034538, 10 pages.
Office Action for European Application No. 16166656, dated Jul. 29, 2020, 7 pages.
Office Action for Chilean Application No. 201701486 dated Nov. 11, 2019, 10 pages.
Office Action for Chinese Application No. 201480031296.1 dated Mar. 27, 2017, 13 pages.
Office Action For Chinese Application No. 201780020023.0, dated Mar. 8, 2021, 19 pages.
Office Action dated Jun. 2, 2016 for Chinese Application No. 201380038075.2, 7 pages (with translation—19 pages).
Office Action dated Sep. 11, 2017 for Chinese Application No. 201480024988.3, 10 pages.
Office Action dated Dec. 12, 2018 for Korean Application No. 10-2017-7015164, 3 pages.
Office Action dated Jun. 15, 2018 for Korean Application No. 10-2017-7015164, 13 pages.
Office Action dated Mar. 16, 2020 for Chinese Patent Application No. 201610255788.X, filed Oct. 21, 2009, 21 pages.
Office Action dated Jan. 18, 2017 for Chinese Application No. 201480024978.X, 8 pages.
Office Action dated Jul. 18, 2018 for Chinese Application No. 201580022356.8, 15 pages.
Office Action dated Sep. 22, 2017 for Russian Application No. 2014120213, 11 pages.
Office Action dated Jan. 25, 2019 for European Application No. 17189951.1, 4 pages.
Office Action dated Jun. 26, 2018 for Japanese Application No. 2017-530762, 16 pages.
Office Action dated Nov. 26, 2019 for Brazilian Application No. 112015000872, 4 pages.
Office Action dated Oct. 26, 2016 for Russian Application No. 2014120213, 7 pages.
Office Action dated Sep. 27, 2019 for Korean Application No. 10-20197005785, 13 pages.
Office Action dated Dec. 30, 2016 for Chinese Application No. 201480024988.3, 26 pages.
Office Action dated Sep. 30, 2018 for Chinese Application No. 201610371843.1, 8 pages.
Office Action dated May 4, 2018 for Chinese Application No. 201610086101.4, 7 pages.
Office Action dated Dec. 5, 2017 for Japanese Application No. 2016-564977, 6 pages.
Office Action dated Apr. 10, 2019, for Korean Application No. 1020167018457, 13 pages.
Office Action dated Apr. 23, 2018 for Chinese Application No. 201580006377.0, 9 pages (20 pages with translation).
Office Action dated Dec. 8, 2017, for Korean Application No. 1020167020977, 13 pages.
Office Action dated Jan. 23, 2018, for Japanese Application No. 2016548373,3 pages, (6 pages with translation).
Office Action dated Jun. 5, 2018, for Chinese Application No. 201610552323.0, 11 pages, (18 pages with translation).
Office Action dated Mar. 14, 2018, for Russian Application No. 2016131333, 7 pages (13 pages with translation).
Opposition Statement dated Mar. 30, 2017 for Japanese Patent No. 5960358, 144 pages (No translation available).
Partial EPO Opposition, resulting in interlocutory decision dated Aug. 7, 2019, 75 pages.
Rudolph G., “The Influence of CO2 on the Sensory Characteristics of the Favor-System,” 1987, Accessed at http://legacy.library.ucsf.edu/tid/sld5f100, 24 pages.
Search Report for Chilean Application No. 2019-11665, dated Nov. 11, 2019, 10 pages.
Search Report for Japanese Application No. 2011532464, dated Sep. 18, 2013, 116 pages.
Search Report for Japanese Application No. 2014-179732, dated Sep. 9, 2015, 12 pages.
Search Report for Japanese Application No. 2016134648, dated Mar. 28, 2017, 29 pages.
Search Report for Japanese Application No. 2016-564977, dated Oct. 25, 2017, 19 pages.
Search Report for Japanese Application No. 2011532464, dated Sep. 24, 2013, 53 pages.
Search Report dated Feb. 1, 2017 for Japanese Application No. 2016517671, 13 pages.
Search Report dated Apr. 14, 2017 for Japanese Application No. 2016-134648, 31 pages.
Search Report dated Sep. 19, 2013 for Japanese Application No. 2011-532464, 116 pages.
Search Report dated Apr. 24, 2017 for Russian Application No. 2015146843, 3 pages.
Search Report dated Jun. 24, 2019 for Russian Application No. 2018137583, 2 pages.
Search Report dated Apr. 25, 2018 for Chinese Application No. 201610086101.4, 1 page.
Search Report dated Aug. 25, 2015 for Japanese Application No. 2014-179732, 10 pages.
Search Report dated Oct. 25, 2017 for Japanese Application No. 2016-864977, 19 pages.
Search Report dated Apr. 29, 2019 for Russian Application No. 2018137501, 12 pages.
Search Report dated May 29, 2015 for Great Britain Application No. 1422018, 3 pages.
Search Report dated Mar. 20, 2015, for Great Britain Application No. GB1401520.0, 2 pages.
Second Office Action dated Aug. 20, 2013 for Chinese Application No. 200980152395.4, 16 pages.
Sharafat et al., “Ceramic Foams: Inspiring New Solid Breeder Materials,” 12th International Workshop on Ceramic Breeder Blanket Interactions, Germany, Sep. 16-17, 2004, 22 pages.
Supulveda et al., “Processing of Cellular Ceramics by Foaming and In Situ Polymerisation of Organic Monomers,” Loughborough University, 1999, 22 pages.
Wires.co.uk, “Bare Nickel Chrome/Nichrome Section,” Jun. 20, 2012, 33 pages.
Wires.co.uk, “Specialist in Craft Wire,” Jun. 20, 2012, 5 pages.
Written Opinion for Application No. PCT/AT2009/000413, dated Jan. 25, 2010, 5 pages.
Written Opinion for Application No. PCT/AT2009/000414, dated Jan. 26, 2010, 14 pages.
Written Opinion for Application No. PCT/AT2012/000017, dated Jul. 3, 2012, 4 pages.
Written Opinion for Application No. PCT/GB2014/051633, dated Dec. 4, 2014, 11 pages.
Written Opinion for Application No. PCT/GB2014/051688, dated Aug. 26, 2014, 4 pages.
Written Opinion for Application No. PCT/GB2015/051213, dated Jul. 16, 2015, 9 pages.
Written Opinion dated Jun. 23, 2014 for Application No. PCT/EP2013/064922, filed Jul. 15, 2013, 4 pages.
Written Opinion of the International Preliminary Examining Authority for Application No. PCT/GB2015/050195 dated Jan. 20, 2016, 8 pages.
Written Opinion of the International Searching Authority for Application No. PCT/GB2015/050195, dated Sep. 2, 2015, 8 pages.
Written Opinion of the International Preliminary Examining Authority for International Application No. PCT/GB2015/051213 dated Mar. 29, 2016, 9 pages.
“Addictiveness and Attractiveness of Tobacco Additives”, written procedure, European Commission Directorate-General for Health & Consumers, Scientific Committee on Emerging and Newly Identified Health Risks, SCENIHR , Jul. 6, 2010 , 112 pages.
“Bringing attention to e-cigarette pH as in important element for research and regulation”, Tobacco Control, vol. 24, No. 4 , May 14, 2014 , 2 Pages.
“Certified Priority document of WO2015091258, Priority No. EP13198390.0, Priority date: Nov. 12, 2013”.
“Chilean Office Action, Application No. 201701108, dated Aug. 20, 2018”.
“Chilean Office Action, Application No. 201701137, dated Aug. 20, 2018”.
“Chinese Office Action, Application No. 201580060720.X, dated Dec. 4, 2017”.
“Chinese Search Report, Application No. 201580061121.X, dated Jan. 23, 2018”.
“Consolidated list of citations—EP3214957”, Nov. 19, 2019.
“Corrected Affidavit of Andrew Allan Burton”, Submitted in Counterpart Application EP 3491941 , Oct. 15, 2021 , 8 Pages.
“Decision to Grant for Russian Application No. 2017105898, dated Mar. 16, 2018”.
“Declaration by Connor Bruton dated Feb. 27, 2020 filed on the corresponding U.S. application, U.S. Appl. No. 15/525,194”, some pages have been incorrectly labelled U.S. Appl. No. 15/525,163 , 8 pages.
“Declaration of Adam Bowen”, Feb. 28, 2022.
“Declaration of Daniel Myers”, Mar. 2, 2022.
“Declaration of John McKean”, European Patent Application No. 15794254.1 (EP3214957B), Opposition: Nerudia Limited , Nov. 12, 2019 , 1 Page.
“Declaration of Joseph P. Hamilton”, Hamilton Declaration , Nov. 8, 2019 , 7 Pages.
“Declaration of Marc Doring”, Nov. 12, 2019.
“Declaration of Sara Luisa Mellor de Sousa”, European Patent Application No. 15794254.1 (EP3214957B), Opposition: Nerudia Limited , Nov. 11, 2019 , 1 Page.
“Declaration of William Ward III”, Feb. 28, 2022.
“eRoll pictures metadata”, Nov. 11, 2019.
“European Patent Office Boards of Appeal Datasheet for the Decision for T405/13, Application No. 03077709.8”, Apr. 9, 2014.
“European Search Report for Application No. 22155057.7, mailed on Jun. 15, 2022”.
“Extended European Search Report for Application No. 19196432.9, mailed on Dec. 9, 2019”.
“Extended European Search Report for Application No. 20183945.3, mailed Oct. 13, 2020”.
“Extended European Search Report for European Application No. 18212381.0, mailed Apr. 15, 2019”.
“Extraction from the Register of European Patents of 3082484 (WO2015091258) downloaded Dec. 11, 2019”.
“Feature Analysis of Claim 1”, BATMark Limited, Opposition Against EP3117860B1, Exhibit D6 , Oct. 30, 2019 , 1 Page (Official Copy Only).
“Federal Register”, Federal Register Doc .99-7022 , Mar. 23, 1999 , pp. 14,086-14,096.
“Great Britain Search Report, Application No. GB1419865.9, dated May 7, 2015”.
“Great Britain Search Report, Application No. GB1419866.7, dated May 7, 2015”.
“Great Britain Search Report, Application No. GB1517361.0, dated Feb. 8, 2016”.
“Health Risk of BPA in Ecig Products”, ECF, https://www.e-cigarette-forum.com/threads/health-risk--of-bpa-in-ecig-products.443140/ , Jul. 16, 2013 , 4 Pages.
“International Preliminary Report on Patentability for Appl. No. PCT/GB2016/053051, mailed on Nov. 27, 2017”.
“International Preliminary Report on Patentability, International Application No. PCT/GB2015/053368, mailed Feb. 3, 2017”.
“International Preliminary Report on Patentability, International Application No. PCT/GB2015/053369, Mailed Oct. 7, 2016”.
“International Search Report and Written Opinion, Application No. PCT/GB2016/053051, mailed Jan. 2, 2017”.
“International Search Report and Written Opinion, International Application No. PCT/GB2015/053369, Mailed Feb. 5, 2016”.
“International Search Report and Written Opinion, PCT/GB2015/053368, mailed Jan. 15, 2016”.
“Japanese Decision to Grant, Application No. 2017-523309, dated Jul. 24, 2018”.
“Japanese Office Action, Application No. 2017-523310, dated Apr. 10, 2018”.
“Japanese Search Report, Application No. 2017-523310, dated Jan. 23, 2018”.
“Juul Labs Delivery message”, Messenger Receipt 2p—Ball, Krystine , Nov. 11, 2019 , 2 Pages.
“Korean Office Action, Application No. 10-2017-7012228, mailed Oct. 22, 2018”.
“Korean Office Action, Application No. 10-2017-7012229, mailed Oct. 22, 2018”.
“Letter Accompanying Corrected Affidavit of Andrew Allan Burton”, Submitted in Counterpart Application EP 3491941 , Oct. 18, 2021 , 1 Page.
“Letter from Patentee for European Application No. 17189951.1, dated Aug. 21, 2018”.
“Look What My Banana Juice Did To My Tank!”, Planet of the Vapes, https://www.planetoflhevapes.co.uk/forums/ecig-discussion/general-chat/threads/look-what-my-banana-juice-did-to-my-tank.3083/ , Sep. 22, 2012 , 6 Pages.
“Measuring pH of Non-Aqueous and Mixed Samples”, Thermo Fisher Scientific, Application Note 007, document reference AN-PHNONAQS-E 1014 Rev A, 2014 , 4 Pages.
“Mil-G-45204 Military Specification: Gold Plating”, Electrodeposited [S/S By MIL-DTL-45204D], Jun. 7, 1983 , 18 Pages.
“Notice of Allowance received for Korean Patent Application No. 10-2017-7012228, mailed on Apr. 28, 2019”.
“Notice of Opposition—Imperial Tobacco Limited for European Application No. 20171293.2, mailed on Nov. 16, 2022”.
“Notice of Opposition—Philip Morris for European Application No. 20171293.2, mailed on Nov. 17, 2022”.
“Notice of Opposition mailed May 25, 2021 for European Application No. 15794253.3 (EP3214956)”.
“Notice of Opposition to EP3214957 B1, filed by George W. Schlich, Nov. 13, 2019”.
“Notice of Opposition to EP3214957, filed by Plate Schweitzer Zounek, Nov. 13, 2019”.
“Notice of Reasons for Rejection for Japanese Application No. 2020-121265, mailed on Jun. 21, 2022”.
“Notice of Reasons for Rejection received for Japanese Application No. 2020-181572 mailed on Feb. 14, 2023”.
“Notice of Reasons for Rejection received for Japanese Patent Application No. 2020-121265, mailed on Apr. 11, 2023”.
“Notification of First Office Action for Chinese Application No. 2018103833246, dated Jun. 3, 2020”.
“Notification to Grant received for Chinese Patent Application No. 201610256674.7, mailed on Jan. 12, 2023”.
“Observations on the Grounds of Appeal for European Patent No. 3214957 (15794254.1), mailed Apr. 14, 2022”.
“Occupational Health Guideline for Nicotine”, U.S. Department of Labor, Occupational Safety and Health Administration , Sep. 1978 , 6 Pages.
“Office Action For Korean Application No. 10-2018-7031081, mailed on Dec. 15, 2021”.
“Office Action for Ukraine Application No. a201810662, mailed Jul. 22, 2022”.
“Office Action mailed Aug. 5, 2020 for European Application No. 15794254.1”.
“Office Action received for Canadian Patent Application No. 2,964,829, mailed on Jun. 5, 2023”.
“Office Action received for Chinese Patent Application No. 2020105247754, mailed on Feb. 28, 2023”.
“Office Action received for European Patent Application No. 16777777.0, mailed on Jun. 15, 2020”.
“Opposition to EP3214957, filed by JT International, Bandpay & Greuter, Nov. 13, 2019”.
“Opposition to EP3214957, filed by Nerudia Limited, Newburn Ellis”, Nov. 13, 2019.
“Oral Proceedings for the Opposition of European Patent No. 3214957 (15794254.1), mailed Jun. 25, 2021”.
“Picture of the atomizer of the “eRoll””, Nov. 11, 2019.
“Picture of the atomizer of the “eRoll”e-cigarette”, Oct. 30, 2019.
“Picture of the atomizer of the “Wick of the eRoll E-Cigarette””, Nov. 10, 2019.
“QQ-S-365D Federal Specification: Silver Plating”, Electrodeposited, General Requirements For , Jun. 3, 1985 , 12 Pages.
“Reply of the patent proprietor to the notice(s) of opposition Patent No. 3491941 (18212381 ), dated Oct. 7, 2021”.
“Reply to Grounds of Appeal, for European Patent No. 3214957 (15794254.1), mailed Apr. 20, 2022”.
“Report on determining the cartridge material of the eRoll E-Cigarette”, Analysis of an eRoll cartridge, Annex D4c , Nov. 10, 2019 , 3 Pages.
“Response Filed in Opposition to European Patent No. 3214956 on Oct. 15, 2021”.
“Results”, May 11, 2019.
“Results”, Apr. 11, 2019.
“Russian Office Action, Application No. 2018111280, dated Dec. 10, 2018”.
“Screenshot of “Joyetech eRoll Manual””, Retreived from the Internet: URL: https://www.joyetech.com/download/?mid=1145 , Oct. 5, 2012 , 1 Page.
“Search Report for Japanese Application No. 2018-546893, mailed Nov. 25, 2019”.
“Search Report mailed Jan. 21, 2020 for Chinese Application No. 201680056890.5”.
“Search Report mailed Mar. 8, 2021 for Chinese Application No. 2019101103915”.
“Sex, GABA, and Nicotine: The Impact of Smoking on Cortical GABA Levels Across the Menstrual Cycle as Measured with Proton Magnetic Resonance Spectroscopy”, Biol Psychiatry , Jan. 1, 2005 , 12 Pages.
“Signed Affidavit of Andrew Allan Burton”, Submitted in Counterpart Application EP 3491941 , Oct. 7, 2021 , 8 pages.
“The E-Cigarette Industry, Waiting to Exhale”, Wayback Machine archive of Article in New York Times: https://www.nytimes.com/2013/10/27/business/thee-cigarette-industry-waiting-to-exhale.html., NY Times article dated Oct. 26, 2013, XP055656051 , Oct. 28, 2013 , 12 Pages.
“The Vapor Pro”, available at URL: https://web.archive.org/web/20140223102416/http://www.thevaporpro.com/faq.html. , Feb. 23, 2014 , 27 Pages.
“Wayback Machine archive of The Vapor Pro”, website: http://www.thevaporpro.com/faq.html , Sep. 11, 2013 , 19 Pages.
“Wikipedia entry for Lik Hon”, https:/ /en.wikipedia.org/wiki/Hon Lik , Oct. 18, 2019 , 4 Pages.
“Witness Statement Noori Brifcani”, May 6, 2021.
“Written Opinion of International Preliminary Examining Authority, International Application No.: PCT/GBZ015/053368, mailed Oct. 4, 2016”.
“Written Opinion, Application No. PCT/GBZ016/053051, mailed Aug. 16, 2017”.
Amsterdam , “Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction”, Life Sciences, vol. 79, No. 21 , 2006 , pp. 1969-1973.
Armitage AK, D K Turner , “Absorption of nicotine in cigarette and cigar smoke through the oral mucosa”, Nature, 226 , 1970 , pp. 1231-1233.
ASTM , “Standard Specification for Electrodeposited Coatings of Gold for Engineering Uses”, B488-11 , 2011 , 6 Pages.
Barsanti KC , et al. , “Tobacco smoke particulate matter chemistry by NMR”, Magnetic Resonance in Chemistry, vol. 45 , 2007 , pp. 167-170.
Berlin, I.; M. Anthenelli, R. , “Monoamine oxidases and tobacco smoking”, The International Journal of Neuropsychopharmacology, vol. 4, No. 1, doi:10.1017/SI461145701002188. PMID 11343627 , 2001 , pp. 33-42.
Bowen , et al. , “U.S. Appl. No. 61/912,507, filed on Dec. 5, 2013”.
Britton M , et al. , “Impact of Health Technology Assessments, Some Experiences of SBU”, Int J Technol Assess Health Care, vol. 18, No. 4 , 2002 , pp. 824-831.
Chakraborty S , “Mediated Electrocatalytic Oxidation of Bioanalytes and Biosensing of Glutamate using Functionalized Multiwall Carbon Nanotubes-biopolymer Nanocomposite”, Journal of Electroanalytical Chemistry, vol. 609, No. 2 , Nov. 1, 2007 , pp. 155-162.
Clayton , et al. , “Spectroscopic Investigations into the Acid-base Properties of Nicotine at Different Temperatures” , Analytical Methods. RSC Publishing, vol. 5 , 2013 , pp. 81-88.
Clayton P M , et al. , “Use of chiroptical spectroscopy to determine the ionisation status of (S)-niotine in e-cigarette formulations and snus”, ST49, Coresta Congress, Quebec City, Canada, Available at: http://www.bat-science.com/groupms/sites/BAT_9GVJXS.nsf/vwPagesWebLive/DO9PVC3G/$FILE/CORESTA_PC_2014.pdf. , Oct. 12-16, 2014 , 16 Pages.
Cymes G D , “The Unanticipated Complexity of the Selectivity—Filter Glutamates of Nicotinic Receptors”, Nature Chemical Biology, vol. 8, No. 12 , Dec. 2012 , pp. 975-981.
Dankwa , et al. , “Aids to Smoking Cessation”, New Zealand Medical Journal, vol. 110, No. 1041 , Apr. 11, 1997 , pp. 131-132.
Deals or Duds , “Why Do Some E-liquids Crack Plastic Tanks?”, Retrieved from the Internet: https://www.dealsorduds.com/guides/e-liquids-crack-plastic-tanks/ , Apr. 26, 2014 , 14 Pages.
Dongmei , et al. , “Catalytic Mechanism of Cytochrome P450 for 5′-Hydroxylation of nicotine: Fundamental Reaction Pathways and Stereoselectivity”, Journal of American Chemical Society, vol. 133, No. 19 , May 18, 2011 , pp. 7416-7427.
Duell AK. , et al. , “Free-base Nicotine Determination in Electronic Cigarette Liquids by 1 H NMR Spectroscopy”, Chemical Research in Toxicology, vol. 31 , 2018 , pp. 431-434.
Durazzo T C , “Chronic Cigarette Smoking in Alcohol Dependence: Associations with Cortical Thickness and N-Acetylasparate Levels in the Extended Brain Reward System”, Addict Biology, vol. 18, No. 2 , Mar. 2013 , pp. 379-391.
Ei-Hellani A , et al. , “Quantification of free-base and protonated nicotine in electronic cigarette liquids and aerosol emissions”, Chemical Research in Toxicology, vol. 28, No. 8, Aug. 17, 2016 , pp. 1532-1537.
EV, Stockel , “Technical Report”, Jun. 24, 2021 , 1 Page.
Fowler , et al. , “Brain monoamine oxidase A inhibition in cigarette smokers”, Proceedings of the National Academy of Sciences of the United States of America, vol. 93, No. 24 , Nov. 1996 , pp. 14065-14069.
Fowler , et al. , “Inhibition of monoamine oxidase B in the brains of smokers”, Nature, vol. 379 , Feb. 22, 1996 , pp. 733-736.
Fox, Lindsay , “10 Coolest E-Cig Mods, ecigarettes”, available from http://ecigarettereviewed.com/coolest-e-cigs-mods, retrieved on Nov. 15, 2016 , 18 Pages.
Giannos S A , “Temporally Controlled Drug-Delivery Systems—Coupling of pH Oscillators with Membrane-Diffusion”, Journal of Pharmaceutical Sciences, vol. 84, No. 5 , May 1995 , pp. 539-543.
Glueck C J , “Nonpharmacologic and Pharmacologic Alternation of High-Density Lipoprotein Cholesterol: Therapeutic Approaches to Prevention of Atheroschlerosis”, Am Heart Journal, vol. 110, No. vol. 110, No. vol. 110, No. 5 , Nov. 1985 , pp. 1107-1115.
Henningfield J.E. , et al. , “Estimation of available nicotine content of six smokeless tobacco products”, Tobacco Control, vol. 4 , 1995 , pp. 57-61.
JoyeTech , “eGo-C Atomizer body”, Retrieved from the Internet: https://www.joyetech.com/producl/ego-c-atomizer-body/ , 2019 , 3 Pages.
JoyeTech , “eGo-C Atomizer head”, Retrieved from the Internet: https://www.joyetech.com/producl/ego-c-atomizer-headl, 2019 , 2 Pages.
JoyeTech , “eGo-C Starter Kits”, Retreived from the Internet: https://www.joyetech.com/producl/ego-c-starter-kit/ , 2019 , 3 Pages.
JoyeTech , “eGo-T A Type Transparent Empty Cartridge (5Pcs)”, Retrieved from the Internet: https://www.oyetech.com/producl/ego-t-a-type-transparent-empty-cartridge5pcs/ , 2019 , 2 Pages.
JoyeTech , “eRoll Battery”, Retreived from the Internet: https://www.joyetech.com/producl/eroll-battery/ , 2019 , 2 Pages.
JoyeTech , “e-roll Empty Cartridge”, Retreived from the Internet: https://www.joyetech.com/producl/eroll-empty-cartridge/ , 2019 , 2 Pages.
JoyeTech. , “Edited Drawing and translation”, Shenzhen Jianyiteke Science & Technology Co Ltd, translation Apr. 14, 2021 , Oct. 19, 2012 , 2 Pages.
JoyeTech , “e-roll Starter Kits”, Retrieved from the internet: https://www.joyetech.com/producl/eroll-starter-kil/ , 2019 , 4 Pages.
JoyeTech , “eRoll Starter Kit”, eRoll series, E-Cigarette, Printout Wayback Machine for the webpage: http://www.joyetech.com/product/details.php?gno-123 , Oct. 26, 2014 , 4 Pages.
JWEI Group , “About JWEI”, downloaded May 5, 2021 , 2019 , 3 Pages.
JWEI Group. , “Zoominfo”, downloaded May 5, 2021.
Kalantari-Dehaghi M , et al. , “Mechanisms of Mitochondrial Damage in Keratinocytes by Pemphigus Vulgaris Antibodies”, Journal of Biological Chemistry, vol. 288, No.23 , Jun. 7, 2013 , pp. 16916-16925.
Keithl , et al. , “Industry research on the use and effects of levulinic acid: a case study in cigarette additives”, Nicotine Tobacco Research, vol. 7, No. 5 , Oct. 2005 , pp. 761-771.
Kovacic , et al. , “Iminium Metabolite Mechanism of Nicotine Toxicity and Addiction: Oxidative Stress and Electron Transfer”, Medical Hypotheses. vol. 64, No. 1 , 2005 , pp. 104-111.
Leffingwell , “Leaf Chemistry BA Basic Constituents of Tobacco Leaf and Differences among Tobacco Types”, Blackwell Science XP055326787. Retrieved from the Internet: URL: http: www.leffingwell.com/download/Leffingwell- Tobacco production chemistry and technology.pdf. , Jan 1, 1999 , pp. 265-284.
LiteCig, USA , “Orders and Confirmations”, 2013 , 13 Pages.
Mashhoon , et al. , “Anterior Cingulate Proton Spectorscopy Glumate Levels Differ as a Function ofSmoking Cessation Outcome”, Prog Neuropsychoparmacol Biol Psychiatry, vol. 35, No. 7 , Aug. 15, 2011 , pp. 1709-1713.
McAdam , et al. , “Application and File History for U.S. Appl. No. 15/525,194, filed May 8, 2017”.
McAdam , et al. , “Application and File History for U.S. App. No. 15/764,612, filed Mar. 29, 2018”.
McAdam , et al. , “Application and File History for U.S. Appl. No. 15/525,163, filed May 8, 2017”.
Morie G P , “Fractions of protonate and unprotonated nicotine in tobacco smoke at various pH”, Tobacco Science, 56 (ISSN: 0082-4623). , 1972 , p. 167.
Newton , et al. , “New OTC drugs and Devices 2002, a Selective Review”, J Am Pharm Assoc, vol. 44, No. 2 , Mar.-Apr. 2004 , pp. 211-225.
O'Neill , et al. , “Thalamic Glutamate Decreases with Cigarette Smoking”, Psychopharmacology, (Berlin), Feb. 18, 2014, Epub ahead of print), vol. 231, No. 13 , Jul. 2014 , pp. 2717-2724.
Pankow J F , “Conversion of Nicotine in Tobacco Smoke to its Volatile and Available Free-Base Form Through the Action of Gaseous Ammonia”, Environmental Science & Technology, vol. 31, No. 8 , Aug. 1997 , pp. 2428-2433.
Pankow J F , “Percent Free Base Nicotine in the Tobacco Smoke Particulate Matter of Selected Commercial And Reference Cigarettes”, Chemical Research in Toxicology, vol. 16, No. 8 , Aug. 2003 , pp. 1014-1018.
Perfetti T A , “Structural Study of Nicotine Salts”, Beitrage zur Tabakforschung International, vol. 12, No. 2 , Jun. 1983 , pp. 43-54.
Petrov , et al. , “Two-electron transfer reactions in proteins: bridge-mediated and proton- assisted processes”, Phys Rev E Stat Nonlin Soft Matter Phys, vol. 68, part 1, Jun. 19, 2016, epub Dec 31 2003. , Dec. 2003 , 2 pages.
Poindexter , et al. , “The isolation of harmane and norharmane from tobacco and cigarette smoke”, Phytochemistry, vol. 1, No. 3 , 1962 , pp. 215-221.
Pongjanyakul , et al. , “Alginate-magnesium aluminium silicate films for buccal delivery of nicotine”, Colloids and Surfaces B: Biointerfaces, vol. 74 , 2009 , pp. 103-113.
Pongjanyakul , et al. , “Influence of pH modifiers and HPMC viscosity grates on nicotine- magnesium aluminium silicate complex loaded buccal matrix tablets”, AAPS PharmSciTech, Vo. 13. No. 2 , 2012 , pp. 674-685.
Sae , “AMS 2410K Plating, Silver”, Nickel Strike, High Bake , Apr. 19, 2010 , 4 Pages.
Sae , “AMS 2411H Plating, Silver”, for High Temperature Applications , Dec. 17, 2013 , 4 Pages.
Sae , “AMS 2412K Plating, Silver”, Copper Strike, Low Bake , Jan. 26, 2015 , 4 Pages.
Sastri, V.R. , “Plastics in Medical Devices: Properties, Requirements and Applications”, 2010 , pp. 100,226,230.
Seeman , et al. , “The Form of Nicotine in Tobacco. Thermal Transfer of Nicotine and Nicotine Acid Salts to Nicotine in the Gas Phase”, in J Agric Food Chern, vol. 47 , 1999 , pp. 5133-5145.
Spinefuel , “Smoktech 510 Screw Tank & 510 Pro DCTank Combo Review”. https://spinfuel.com/smoktech-51 0-screw-tank-510-pro-dctank-combo-review/ , Sep. 28, 2012 , 4 Pages.
VAPEGRL , “Silver and Gold E-cigarettes”, vapegrl.com, Available from: http://vapegrl.com/silver-gold-e-cigarettes/ , Feb. 15, 2016 , 8 Pages.
VAPERANKS , “Luxury Customization Company Launches 24ct-Gold-Plated E-Cigarettes”, vaperanks.com, as available from: http://vaperanks.com/luxury-customization-company-launches-24ct-gold-plated-e-cigarette/ , Feb. 4, 2016 , 3 Pages.
Vapordna , “Buy Online Electronic Cigrettes and Accesseories at the Best Possible Prices”, https://vapordna.wordpress.com/ , Sep. 9, 2014 , 12 Pages.
Vas , et al. , “Acetoin is a precursor to diacetyl in e-cigarette liquids”, Food and Chemical Toxicology, vol. 133, 110727 , 2019 , 16 pages.
Villegier , et al. , “Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors”, Pharmacol. Biochem. Behav., vol. 76, No. 2 , Sep. 2003 , pp. 267-274.
Vlachou , et al. , “Both GABA(B) receptor activation and blockage exacerbated anhedonic aspects of nicotine withdrawal in rats”, Eur J Pharmacol., vol. 655, No. 1-3 , Mar. 25, 2011 , pp. 52-58.
Ward, William , “Pictures of the “eRoll Battery””, Juul, email Nov. 11, 2019 , 7 Pages.
Wikipedia , “Electronic Cigarette”, Available at <https://en.wikipedia.org/w/index.php?title=Electronic_cigratte&oldid=284227163>, Apr. 16, 2009 , 7 Pages.
Yao, Jason , “Email from Jason Yao”, Mar. 16, 2021 , 1 Page.
Zhang , et al. , “Quantitative Analysis of Six Heterocyclic Aromatic Amines in Mainstream Cigarette Smoke Condensate Using Isotope Dilution Liquid Chromatography—Electrospray Ionization Tandem Mass Spectrometry”, Nicotine & Tobacco Research vol. 13, No. 2, doi: 10.1093/ntr/ntq219. , 2010 , pp. 120-126.
“Shenzhen Jianyiteke Science & Technology Co Ltd”, Oct. 19, 2012, 1 Page.
ASTM , “B700-8 Standard Specification for Electrodeposited Coatings of Silver for Engineering Use”, 2014, 5 Pages.
Barr P. , “Technical Analysis of Joyetech eRoll cartridge and Joyetech eGo-C cartridge”, Nov. 12, 2019, 3 Pages.
EV Stockel , “Technical Report”, Nov. 8, 2019, 3 Pages.
EV Stockel , “Technical Report on Absorption Behaviour of Protonated Nicotine”, Jul. 9, 2020, 5 Pages.
GoldGenie , “A 24 carat gold-plated electronic cigarette E-cigarette reviews and rankings”, Feb. 17, 2014, 6 Pages.
JoyeTech , “The eRoll—User Manual”, Oct. 5, 2012, 9 Pages.
Matt, Richtel , “The E-Cigarette Industry, Waiting to Exhale”, New York Times, Oct. 26, 2013, 8 Pages.
Patel, “Structural studies of Impatiens balsamina antimicrobial protein (Ib- AMPI)”, Biochemistry, vol. 37, No. 4, Jan. 27, 1998, pp. 983-990.
Pinggera, et al., “Urinary acetonitrile concentrations correlate with recent smoking behaviour”, BJU International, vol. 95, No. 3, Sep. 20, 2004, pp. 306-309.
Sae , “AMS 2422F Plating, Gold”, Feb. 6, 2014, 2 Pages.
Sami , “Studies on electron transfer reactions of Keggin-type mixed addenda heteropolytungstovanadophosphates with NADH”, Journal of Chemical Sciences, vol. 121, No. 2, Mar. 2009, pp. 155-161.
Tripathi, D. , “Practical Guide to Polypropylene”, Rapra Technology Ltd, 2002, pp. 98-99.
Notification of Grant received for CN Appln. No. 2016102566747, mailed Jan. 12, 2023, 7 pages.
Related Publications (1)
Number Date Country
20210204602 A1 Jul 2021 US
Continuations (3)
Number Date Country
Parent 15997113 Jun 2018 US
Child 17248137 US
Parent 14268909 May 2014 US
Child 15997113 US
Parent 13984512 US
Child 14268909 US